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AIM AND SCOPE OF THIS THESIS
It has been well documented that cell-mediated killing by
immune cells is an important defence mechanism against the
proliferation of tumour cells. Over the last few years
considerable work have been done in uncovering the mechanisms by
which cytotoxic cells kill their tumour targets. The aim of this
thesis project is to study how normal lymphocytes can be
activated to kill syngeneic and allogeneic tumour cells of known
antigenicity. Attempts will also be made to modulate their lytic
potential in view of enhancing their ability to restrict the
growth and dissemination of malignant cells.
In the work presented in this thesis, three different
experimental approaches have been adopted for studying the
activation and modulation of lymphocyte-mediated cytotoxicity
against tumours. These include (1) the direct induction of
lymphocyte-mediated killing against tumours by mitogenic plant
lectins; (2) the nonspecific triggering of cytotoxicity against
tumours by pharmacologic agents that can mimic antigenic stimuli
in inducing transmembrane signalling in lymphocytes; and (3) the
generation of ''tumour-specific' cytotoxic T lymphocytes by a
combination of in vivo and in vitro immunization techniques. The
philosophy of the present study is to enlarge our basic knowledge
and understanding of the properties and the functional roles
played by various types of cytotoxic lymphocytes in the host
defence against malignant tumours. It is hoped that the
manipulation of the cytotoxic response in vitro may provide us
with better insights into the signal transduction mechanisms in
cell-mediated cytotoxicity.
CHAPTER ONE: GENERAL INTRODUCTION
CONTENTS
1.1 Cell-mediated cytotoxicity in the defence of host against
tumour growth and metastasis
1.1.1 Cytotoxic T lymphocytes
1.1.2 Natural killer cells
1.1.3 Macrophages
1.1.4 Cell-mediated cytotoxicity via 'conferred
specificity': Antibody—dependent cellular
cytotoxicity
1.2 Activation and modulation of lymphocyte-mediated
cytotoxicity against tumours
1.2.1 Induction of nonspecific lymphocyte-mediated
cytotoxicity by lectins
1.2.2 Induction of nonspecific lymphocyte-mediated
cytotoxicity by drugs
1.2.3 Effects of lectins and drugs on signal
transduction in T lymphocytes
1.2.4 Lymphokine-activated killer cells: nonspecific
ki1lers
1.2.5 Specific cytotoxic T cells generated by in
vitro immunization
1.3 Mechanisms of cell-mediated cytotoxicity
The host immune system is composed of two main interacting
branches: cell-mediated and humoral immunity. Cell killing by
immune cells represents an important natural defence barrier
against proliferation of tumour cells, virus-infected cells and
other foreign invaders (Young and Cohn,1986). Natural killer (NK)
cells kill a wide spectrum of tumour cell lines and virus-
infected cells nonspecifically whereas cytotoxic T lymphocytes
(CTL) are major histocompatibility complex (MHC)-restricted and
have antigen specificity. There are also non-MHC restricted
cytotoxic cells expressing T-cell antigens which are present
among lymphocytes activated by lectins, alloantigens, drugs and
other lymphokines. In this introductory chapter, the roles of
cell-mediated cytotoxicity in the defence of host against tumour
growth and metastasis will be reviewed. Moreover, the in vitro
activation of cytotoxic lymphocytes and the multiple mechanisms
of lymphocyte-mediated killing will also be introduced. Because
of the vast literature in these areas, the discussion that
follows is neither comprehensive nor referenced in details. Only
those topics that are most pertinent to the work done in this
thesis will be highlighted.
1.1 Cell-mediated cytotoxicity in the defence of host against
tumour growth and metastasis
It is well known that the immune system is composed of two
major lymphocyte populations: The B cells which are responsible
for antibody production (humoral immunity) and the T cells which
are responsible for specific cell-mediated immunity. The main
function of the immune system is the destruction or elimination
of foreign antigens. It may also generate immunological memory so
that the host will respond much faster in the second
confrontation with the same antigen. On the other hand, it may
lead to the development of immunological tolerance and
suppression. For anti-tumour responses, the immune system may
also play dual roles that it may try to eliminate or destroy the
tumour cells on one end whilst it may also facilitate the growth
and metastasis of tumour mass on the other end (Beverley, 1978;
Naor, 1979).
The anti-tumour mechanisms are depicted in Fig. 1.1. Those
mediated by humoral immunity include antibody-dependent cellular
cytotoxicity (ADCC) and complement-mediated lysis of tumour
cells. The major effector cells involved in ADCC are the
eosinophils, neutrophils, macrophages and killer (K) cells. On
the other hand, thymus-derived (T) lymphocytes are the major cell
type related to the cell-mediated immunity and can be subdivided
functionally into four classes: helper.Tcells, suppressor T cells
, cytotoxic T cells and delayed type hypersensitivity T cells.
Additionally, nonspecific lymphoid cells including K cells, or
null (non-T, non-B) cells, macrophages, lymphokine-activated
killer (LAK) cells and NK cells also play a role in anti-tumour
responses. However, in the following section, my discussion will
mainly be focused on the properties of a few major cell types













































Fig. 1.1 Immunologic mechanisms involved in tumour cell
destruction (Siegel, 1985).
1.1.1 Cytotoxic T lymphocytes:
Cytotoxic T lymphocytes have long been implicated as the
prinicipal effector cells in allograft rejection (Berke, 1980),
tumour immunity (Cerottini and Brunner, 1974) and lysis of virus-
infected cells (Ting and Bonnard, 1976). CTL are the best
characterized killer cells which are antigen- specific and MHC-
restricted. Most CTL are MHC class 1 restricted, but some are MHC
class 2 restricted and the function of these cells is unclear
(Braakman et ad., 1987; Shinohara, 1987). Moreover, some cloned,
interleukin-2 (IL-2)-dependent CD3+T-cell lines are reported to
lyse a broad spectrum of tumour targets without the MHC
restriction although they also recognize targets via the CD3Ti
complex since both anti-clonotypic and anti-CD3 antibodies can
inhibit cytolytic activity. They also rearrange Ti genes. Some
also recognize an activation antigen, designated as TNKar or 4F2
on target cells. This type of cytotoxic T lymphocytes has- been
proposed by Lanier and Philips (1986) as a unique type of CTL-
non-MHC restricted cytotoxic T lymphocytes. This type of CTL may
also include effector cells that are involved in lymphocyte-
mediated cytotoxicity induced by lectins or phorbol esters
andor calcium ionophores as well as the lymphokine-activated
killer activity.
The CTL-mediated lysis of a specific target can be divided
into three phases (Tschopp and Jongeneel, 1988)
1. Recognition and binding: CTL are first adhered to their
target cells nonspecifically by two CTL-cell adhesion molecules
on the cell surface: LFA-1 (lymphocyte -function -associated
protein 1), a heterodimer consisting of an alpha subunit of 180
kD and a noncovantly linked beta subunit of 95 kD, and CD2
(cluster of differentiation), a 45-50 kD glycoprotein. These
molecules interact with the two target cell surface proteins
called ICAM (intercellular adhesion molecule) and LFA-3
respectively. ICAM is poorly defined at the molecular level.
LFA-3 has a molecular weight of 55,000-70,000. This interaction
is Mg++-dependent and strengthened by interactions between the T
cell receptor complex (TiCD3) on the CTL and a combination of
its cognate antigen and major histocompatibility complex coded
molecules on the target cell. The majority of CTL is class-1 MHC
restricted. The T cell receptor consists of the Ti alphabeta
heterodimer which carries the clonal specificity through its
variable regions and the associated CD3 complex. CD3 appears to
be involved in the post-recognition activation step( Spits et
al., 1986). The avidity of these cell-cell interactions is
further enhanced by the binding of CD8 molecule (mouse Lyt-2) to
monomorphic determinants of the appropriate MHC molecule on the
target cells.
2. 'Lethal hit' delivery: Occupation of the CTL causes a local
Ca++influx (Weiss et ad., 1986? Phoenie et ad., 1987) which acts
as a signal for the ''lethal hit' delivery stage. It leads to a
drastic morphological reorganization of the CTL and the
subsequent delivery of molecules 'lethal' to the target cell.
Once the lethal molecules have been released from the CTL, the
CTL then recycle and go on to kill other targets. The lytic
molecules will be discussed later in this chapter.
3. Target cell lysis: CTL-mediated lysis of target cells is
characterized by the dual disintegration of DNA and plasma
membrane of target cells. The disintegration of DNA is not
observed in complement-mediated lysis. During the lytic stage,
massive Ca++influx and changes in the overall shape of the target
cells are followed by dilation of the endoplasmic reticulum and
chromatin condensation (Duvall and Wyllie, 1986). These
morphologic changes are accompanied by DNA fragmentation (Duke et
al., 1983) and finally, the target cells release macromolecules
into the extracellular environment due to cytoplasmic membrane
damage.
1.1.2 Natural killer cells:
Natural killer cells represent a heterogeneous population of
lymphoid cells that generate spontaneous cytotoxic activity
against tumour cells as well as virus-infected cells in vitro
(Kiessling and Wigzell, 1979). NK cells are discovered in the
mid-1970s and soon recognized as potentially important in
the protection against tumour cells and infections, and in
immunoregulation (Moller, 1979; Welsh, 1981; Herberman, 1982).
Moreover, NK cells may also be involved in allogeneic lymphocyte-
mediated cytotoxicity (Fossum and Rolstad, 1986).
NK cells are different from other immune cells by their
morphology, surface phenotype, antigenic markers and target cell
specificity (Ortaldo, 1986). In contrast to cytotoxic T cells, NK
cells have no MHC restriction. They can kill a variety of
syngeneic, allogeneic and xenogeneic tumour cells as well as some
fetal cells, virus-infected cells, chemically-treated cells and
subpopulations of normal lymphoid or hematopoietic stem eel Is. The
cells that are most susceptible to NK lysis in vitro seem to be
those lacking MHC antigen (Karre et al., 1986). In human system,
NK activity is mediated by the large granular lymphocytes (LGL)
that are present in about 5- 10% of the peripheral blood
mononuclear cells( Saksela et al., 1979; Timonen et ad., 1981).
NK cells also express a few common surface markers as macrophages
and also several T cell-associated markers. In the human system,
NK cells lack CD3 surface marker but express CD11 and T-related
markers (CD2, CD8, OKTIO)( Lanier et al., 1985; 1986). In the
murine system, NK cells lack Lyt2 and L3T4 T cell markers but
express the asialo GM1, Ly5, Qa5, NK1 and NK2 on the cell surface
(Jondal, 1987). In addition, a subset of mouse NK cells expresses
Thy 1 (Wiltrout et ad., 1984). Moreover, NK cells are
nonadherent, nonphagocytic cells and express surface receptors
for the Fc portion of IgG (CD16) and thus can mediate an ADCC
reaction. NK cells originate in the bone marrow and exhibit a
characteristic organ distribution. The activity declines from
peripheral blood, spleen, lymph nodes and bone marrow and does
not present in thymus (Herberman et ad., 1975; Kiessling et ad.,
1975). Moreover, NK activity is age-dependent and in the mouse it
is low during the first 3 weeks, peaks at 6-10 weeks old, and
gradually declines thereafter.
Unlike CTL, NK activity does not appear to be dependent on
antigenic sensitization and no secondary memory response has oeen
seen (Herberman, 1974). However, NK activity can be activated in
vivo by a variety of bacterial agents as well as synthetic agents
such as polyinosinic polycytidylie acid( poly I:C) and pyran
copolymer. In addition, they also respond to T-cell mitogens,
IL-2 and interferons in vitro.
Although different aspects of NK cells such as morphology,
phenotype, mode of function and specificity have been extensively
studied, the important question of target cell recognition has
not been resolved (Lanier and Philips, 1986). The expression of
CD2,CD16 and adherence type receptors such as CDllaCD18 on the
NI cell surface may be somehow related to the recognition
process. It has been suggested that NK cells express CD2
receptors in such steric configurations that they both bind and
activate cells in combination with supporting receptors such as
CD16, CDllaCD18 and possibly others. The postulated dual binding
and triggering function of CD2 receptors on NK cells is based on
the demonstration of different functional epitopes within the CD2
receptor molecule( Bernard et a_l., 1986; Meuer et ad., 1986).
On the other hand, there is a double restriction in NK cell
specificity involving two independent but sequential stages in
recognition represented in binding and triggering by high mannose
containing and asparagine-linked oligosaccharide on the tumour
target cell surface (Kiyohara, 1987.)
After recognition of target cells, the next step involves
the triggering of intracellular processes: rearrangement of the
granules and other cytoplasmic organelles towards the site of
binding with the target cells. Finally, NK cells lyse the target
cells by secretion of cytolysin (Schmidt et al.,1986) as well as
other lytic molecules. Moreover, natural killer cytotoxic factor
(NKCF) released by NK cells during the interaction of spleen
cells with NK-susceptible targets may also be involved in the
mechanism of lysis by NK cells. NKCF appears to be relatively
unstable proteins with the molecular weight in the range of
20,000-40,000 (Farram and Targan, 1983). Moreover, NKCF exhibits
some target cell specificity. Besides, it can lyse targets in the
absence of Ca++ and requires 8-12 hours of incubation at 37 °C
but not at 22 °C (Deem et a_l., 1986).
1.1.3 Macrophages:
Macrophages as well as polymorphonuclear leukocytes
constitute the first line of defense of the body against most
infections. Macrophages contribute at several stages in the
specific immunity leading to antibody production and cell-
mediated immunity directed against specific antigens. Moreover,
macrophages also exert a nonspecific anti-bacterial action with
the co-operation of nonspecific opsonins and recognition
factors. Many important biological macromolecules such as
components of complements, transferrin, interferon, arginase and
hydrolytic enzymes such as lysozyme and collagenase are secreted
massively by macrophages. Moreover, macrophages also scavenge
tissue debris, detoxicify certain chemical substances and also
participate in the metabolism and disposition of iron, lipids and
proteins (Neveu, 1986).
In anti-tumour mechanisms, the macrophages play important
roles in both the afferent and efferent arms of the immune
system. Macrophages can act as antigen-presenting cells which
modify and present tumour-specific antigens to T-lymphocytes with
MHC restriction. Moreover, macrophages can lyse the tumours
directly (macrophage-mediated tumour cytolysis, MTC) or through
ADCC. In the MTC process, the cytolysis involves two main steps.
First, the macrophages bind to the tumour targets through
nonspecific~ receptors. Then, the macrophages are activated
and secrete large amount of various cytolytic mediators such as
cytolytic protease (CP), arginase, tumour necrosis factor (TNF),
interferon and hydrogen peroxide. Among them, CP is considered to
be the major lytic molecule in the MTC system (Espevik et al.,
1986). In ADCC system, hydrogen peroxide is reported to be the
major cytolytic agent. However, all mediators may be involved in
the lytic process and the co-operation of them may induce a
synergistic effect. Nonspecifically, macrophages can be
activated by different agents such as endotoxin, double-stranded
RNA to inhibit the growth of lymphoma and sarcoma cells in vitro
or even lyse some malignant tumour targets. Although many reports
showed that macrophages indeed play a role in anti-tumour
mechanism, macrophages are also shown to mediate the
immunosuppression of host lymphocytes which may limit the anti-
tumour activities and enhance tumour growth.
1.1.4 Cell-mediated cytotoxicity via 'conferred specificity':
Antibody-dependent cellular cytotoxicity (ADCC)
Although cytolytic action can be triggered by the specific
interaction between effector cells and target cells (i.e. via
CD3Ti complex or the unidentified NK target receptor), each cell
type may also possess alternative pathways through which target
specificity may be 'conferred' exogenously. In ADCC, antigen
specificity can be conferred by specific IgG antibodies directed
against antigens on the surface of target cells. The effector
cells should thus express Fc receptors for the IgG molecules.
These include a variety of cell types: K cells, macrophages,
neutrophils, eosinophils, NK cells and CD3Ti+ CTL. The mechanism
of killing by ADCC effectors may differ from that of the CTL and
NK cells and will not be discussed here (for review, see Siegel,
1985)
1.2 Activation and modulation of lymphocyte-mediated
cytotoxicity against tumours
It is well known that some weakly immunogenic tumour cells
may not induce a high enough level of immune response in vivo.
Therefore, in order to enhance the anti-tumour cell-mediated
immune responses, different methods have been utilized to induce
a higher level of eel1-mediated cytotoxicity in vitro.
1.2.1 Induction of nonspecific lymphocytes-mediated cytotoxicity
by lectins
Non-MHC restricted cytotoxicity against tumours can also be
mediated by CTL in the presence of certain lectins that are
mitogenic for T cells such as concanavalin A (Con A) and
phytohemagglutinin (PHA). It has been demonstrated that cloned,
antigen-specific, MHC-restricted CTL can lyse inappropriate
tumour targets in the presence of lectins (Bonavida et ad.,
1983). Similarly, alloimmune cells or lectin-activated
splenocytes can kill nonspecifically a wide variety of syngeneic
or autologous cells in the presence of mitogenic lectins such as
Con A and PHA (Forman and Moller, 1973; Bevan and Cohn, 1975;
Bradley and Bonavida, 1978). This has been termed as lectin
dependent cellular cytotoxicity (LDCC). On the other hand, these
lectins do not induce or augment the cytotoxic activity of CD3+
NK cells (Lanier and Phillips 1986). It has been suggested that
lectins mimic specific antigen by interaction with the CD3Ti
complex and cause the initiation of the cytolytic mechanism
(Hubbard et ad., 1986). However, only activation of effector
cells by lectins is not enough to induce lysis of target cells as
it has been demonstrated that activated effector cells do not
lyse target cells when the binding of CTL and target cells is
inhibited (Green, 1982). Moreover, bridging alone is
insufficient for lysis to occur because non-mitogenic lectins
such as soybean agglutinin (SBA) and wheat germ agglutinin (WGA)
do not mediate LDCC though they can cross-link CTL and target
cells (Parker and Martz, 1980). Thus, in LDCC the lectin may
have a dual role: 1. formation of a lectin bridge between
effector cells and target cells and 2. activation of effector
cells. However, it has been found that optimal lysis was obtained
when Con A—treated target cells were allowed to react with
untreated CTL, but not when Con A—treated CTL were reacted with
untreated target cells (Berke et ad., -1981a,b). Similar results
were obtained with PHA. Besides, recent results showed that MHC-
deficient target cells were resistant to LDCC and it was not due
to the inability of the target cells to bind lectins (Keren and
Berke, 1983). Moreover, it has been found that lysis in LDCC can
be blocked efficiently by antisera directed against target cell
MHC-antigens (Ag), but only poorly by sera against non-MHC-Ag
(Berke et ad., 1981b). Therefore, these results suggest that the
lectins may bind to target cell MHC antigens, and perhaps other
cell surface determinants to render the target cell
nonspecifically recognized by CTL receptors. The ability of
monoclonal antibody which is directed against the T-cell antigen
receptor to inhibit both antigen and Con A-mediating lysis
(Sarmiento et. ad., 1982; Hubbard et ad.,1986) further supports
this hypothesis. Moreover, it has been shown that papain-
sensitive, N-linked glycosylated molecules on the target cell
surface must be present for LDCC to occur but not for direct MHC-
specific CTL killing to take place (Gorman et ad., 1987). It has
been suggested that papain-sensitive molecules involved are the
class 1 MHC proteins. Therefore, lectins such as Con A may act on
a glycosylated papain-sensitive component(s) to render the target
cell susceptible to CTL-mediated killing.
LDCC is known to be both calcium and temperature -dependent.
Optimal lysis only occurs at a certain concentration of lectin.
Higher concentrations of lectins (e.g., 100-250 pgml Con A)
showed inhibition of nonspecific killing (Tartof, 1980). LDCC can
also be inhibited by metabolic inhibitors and a-methyl-D-
mannoside (Berke, 1983).
1.2.2 Induction of nonspecific lymphocyte-mediated cytotoxicity
by phorbol esters andor calcium ionophores
Cloned murine cytolytic T lymphocytes as well as normal
human lymphocytes can be triggered by the phorbol ester and
calcium ionophore to lyse a wide variety of tumour target cells
efficiently (Ju et al., 1987; Lancki et al., 1987; Mikael et al.,
1987). Neither phorbol ester nor calcium ionophore alone induce
efficient lysis. Phorbol ester alone has shown to have the
capability of inhibiting the lytic activity of cloned T cells
(Russell, 1984) and NK cells (Abrams et al., 1983) as well as
lectin- and antibody-dependent killing (Jondal et al., 1986).
However, phorbol ester can also induce cloned and in vivo-
produced CTL to lyse weak and nonspecific target cells (Russell,
1986). It may seem paradoxical that a drug which is an activator
of protein kinase C can have an opposite effect on a system that
may depend on the expression of the same enzyme. However, it
should be noted that phorbol ester can rapidly down-regulate cell
surface receptors such as CD4 and Fc receptors for IgG (Solbach,
1982). Moreover, it can also induce a negative feedback
inhibition of the hydrolysis of phosphatidylinositol 4,5-
bisphosphate(PIP2) and thus prevent further formation of inositol
phosphates and diacylglycerol (DG) (Baraban et al., 1985). Such
feedback inhibition is also linked to a block of Ca++ uptake
(Eisenberg et al., 1985). Thus, the effect of phorbol ester on
the lytic ability of cells seems to be determined by the dose
used and the duration of exposure of cells to the drug. For
calcium ionophore, it is also unexpected that it is suppressive
for NK killing even if such killing is considered to depend on an
active Ca++ uptake. Phorbol ester can mimic DG actions to
stimulate protein kinase C and calcium ionophore can increase
intracellular Ca++ levels. It has been demonstrated that the
early steps of murine lymphocyte activation can be bypassed by a
synergy between calcium ionophore and phorbol ester (Truneh et
al., 1985). Moreover, only the combination of the two drugs can
induce IL-2 secretion and expression of IL-2 receptors by T
lymphocytes( Truneh et ad., 1985). With cytotoxic T cell clones,
calcium ionophore and phorbol ester can substitute for antigen in
the induction of killer cells from primed precursors (Alber et
ad., 1985; Isakov and Altman, 1985). The characteristics of the
lytic process induced by the two drugs are similar to that of
antigen-specific or lectin-induced cytotoxicity by CTL. Lysis is
both temperature and calcium-dependent. Besides, phorbol ester
and calcium ionophore can induce both NK cell-enriched, T3-
negative cells and NK cell-depleted, T3-positive cells to lyse
tumour targets (Mikael et al., 1987). Moreover, the drug-induced
killing did not increase the optimal lectin and antibody-
dependent killing (Mikael et ad., 1987).
1.2.3 Effects of lectins and drugs on the signal transduction
in T lymphocytes
T lymphocyte activation and proliferation can be initiated
by interaction between an antigen associated with MHC molecule
or other ligands such as mitogenic plant lectins or drugs and
their corresponding cell surface receptors (Fig. 1.2). Recent
results showed that inositol phospholipid hydrolysis is important
in T-cell activation. In this pathway, interaction of a ligand
with its cell surface receptor stimulates a phosphoinositide-
specific phosphodiesterase (phopholipase C) to hydrolyze
phosphatidylinositol 4,5-bisphosphate (PIP2), a phospholipid
normally found in the cell membrane in minute quantities. GTP-
binding proteins may constitute the coupling mechanism between
receptor occupancy and phospholipase C stimulation. The
hydrolysis products are diacyIglycerol (DG) and inositol 1,4,5-
trisphosphate (IP3)• These two second messengers act
synergistically to elicit a physiological response (Isakov et
al., 1986). DG activates protein kinase C (PKC) by increasing
its affinity for Ca++. Protein kinase C is a single 76-80 kD
polypeptide consisting of two domains: a hydrophilic domain
which possesses the catalytically active center, and a regulatory
hydrophobic domain which binds to Ca++ ,DG and phospholipid.
Upon activation, PKC is translocated from the cytosol to the
membrane and catalyses the phosphorylation of numerous protein
substrates at seryl and threonyl residues by using ATP as a
phosphate donor. Moreover, PKC also stimulates Na+H+ exchanger
and thus leads to an increase in intracellular pH which may be a






































Fig. 1.2 A model of transmembrane signal transduction and
the early intracellular events in T lymphocytes
after activation (Isakov et al.,1986).
second messenger IPg releases Ca++ from the endoplasmic reticulum
and thus increases the concentration of free intracellular Ca++
IP3 may bind to a specific receptor (Spat et al., 1986) and opens
a calcium channel (Muallem et al., 1985) on the endoplasmic
reticulum through a guanine regulatory mechanism (Gill et al.,
1986). IP3 can be phosphorylated to inositol 1,3,4,5-
tetrakisphosphate (IP4) (Irvine et al., 1986) which can act
synergistical ly with a fall in the intracellular calcium pool to
stimulate calcium influx from the extracellular space (Taylor,
1987). This event may activate Ca++-dependent protein kinases
consisting of calmodulin, Ca++,and protein kinases resulting in
protein phosphorylation. As a result, cell surface receptors for
IL-2 appear and the T cell progresses into the mitotic cycle
because of IL-2 production and binding to IL-2 receptor. This
signalling pathway in T lymphocytes has been described in details
(Gelfand et ad., 1987; Isakov et ad., 1987; Linch et ad., 1987).
Lectins are carbohydrate-binding multimeric proteins derived
from plant and animal source. Among the various plant lectins,
Con A is best characterized as a mitogenic protein. Con A
activates T-lymphocytes by binding to a cell surface receptor CD3
antigen without entering the cells (Ballas et ad., 1981). Only
multimeric Con A can stimulate T cells. Monomeric fragments of
Con A are unable to stimulate T cells though they can bind to
them. Since Con A is multimeric,, it can crosslink receptors
between cells leading to cell agglutination (Gunther at a1.,
1973). The cellular reactions mediated by Con A can be divided
into the immediate events which occur in seconds to minutes and
the delayed events which occur in hours or days (Ashman, 1985).
The immediate events include: Con A receptor capping and
patching; rapid changes in K+ and Na+ fluxes; activation of
membrane methyltransferases and phospholipase A2; phospholipid
synthesis and turnover; arachidonic acid metabolism; calcium
influx; cyclic nucleotide changes including cAMP and cGMP;
protein phosphorylation; activation of serine esterases and
increases in membrane transport rates for small molecules. The
delayed events refer to the mitogenic actions of Con A on
lymphocytes. These include acceleration of protein synthesis, RNA
synthesis, polyamine synthesis; changes in carbohydrate
metabolism; blast transformation and finally DNA synthesis
(Robert, 1985). Recently, it has been shown that DNA synthesis
depends critically on the presence of Con A during the first 3
hrs (phase I) and also during a second period around 16- 24 hrs
(phase II) whose exact timing may vary between lymphocyte
subpopulations. In the interim period between 3-16 hrs, the
presence of Con A has little impact on DNA synthesis. The calcium
ionophore A23187 can substitute for Con A during the first period
but not the second indicating that the calcium influx induced by
Con A in phase I is a critical activation event.
Phorbol esters such as phorbol-12-myristate-13-acetate
(PMA) and 12-o-tetradecanoyl-phorbol-13-acetate (TPA) can mimic
the effects of DG and activate PKC without inducing an increase
in intracellular Ca level. On the other hand, calcium ionophores
can mimic the physiological signal of IP3 and increase the
intracellular Ca++levels. The two drugs can act synergistically
on T-cell activation.
Phorbol esters are similar to DG in structure and can
replace DG directly to activate PKC in vitro. The primary site of
their action is specific receptors on the cell membrane and they
initiate biochemical reactions that result in cell activation,
proliferation, differentiation and transformation( Yuspa et
a.,1976; Touraine et ad., 1977; Lotem and Sachs, 1978; Blumberg,
1981). PKC is considered to be the cellular receptor for them.
Phorbol esters can stimulate proliferation of resting human T
cells (Isakov et a_l., 1986; Isakov and Altman, 1987). They
induce expression of IL-2 and transferrin receptors. The
proliferation of T cells is related to PKC activation. Moreover,
this proliferation is not accompanied by IL-2 gene transcription
or IL-2 secretion. Therefore, it may indicate that PKC is
centrally involved in the transduction of activation signals in T
cells and in the regulation of IL-2 receptor induction and
expression. Moreover, the activation of PKC by phorbol esters
leads to phosphorylation of the IL-2 receptors and the T3 complex
in human T cells. On the other hand, phorbol esters can also
downregulate T3 expression on human T cells (Cantrell et al.,
1985; Isakov et al., 1985b; 1986a). It is likely that PKC also
mediates negative feedback regulation of T3 expression. Besides,
it has been reported that TPA can act synergistically with plant
lectins such as Con A and PHA on inducing the production and
secretion of IL—2 and other lymphokines by T cells.
Increased intracellular Ca++level is a critical event in both
signal transduction by various cell surface receptors and T-cell
activation. Antigens, anti-CD3 and anti-Til antibodies as well
as calcium ionophores can stimulate intracellular Ca++ level
increase and thus T-lymphocyte proliferation under appropriate
conditions. The physiological intracellular (Ca++) in resting
cells is normally too low for PKC activation. However, binding of
DG or phorbol esters can increase the affinity of PKC for Ca and
thus allowing it to be partially or fully activated by basal
intracellular Ca+ +level. Alternatively, in the absence of DG or
phorbol ester activation, PKC could be activated by increasing
basal intracellular Ca++level by calcium ionophore. At optimal
concentrations, calcium ionophore alone can trigger IL-2 receptor
expression and human T-cell activation without IL-2 production.
Although phorbol esters and calcium ionophores can activate T
cells independently, they can act synergistically on T-cell
activation at non-mitogenic concentrations and induce high
levels of IL-2 production (Chopra et a., 1987). It may be
concluded that PKC activation is a sufficient signal for IL-2
receptor expression whereas activation of the IL-2 gene requires
both activated PKC and a Ca++signal (Truneh et al., 1985).
However, the signals for DNA synthesis generated by binding of
IL-2 to IL-2 receptors are different from those for IL-2
production and IL-2 receptor expression induced by phorbol esters
and calcium ionophores (Koysau et a_l., 1987; Albert e_t a 1.,
1988).
1.2.4 Lymphokine activated killer cells: nonspecific killers
Lymphokine activated killer cells can be generated by
incubation of spleen cells or peripheral blood leukocytes (PBL)
from normal or tumour-bearing individuals with IL-2 in vitro for
3-5 days. They can kill a wide variety of NK-resistant and fresh
autologous tumour targets (Grim et al., 1982) with no activity
against normal cells (Grim and Rosenberg, 1984). LAK cells are
indistinguishable from T lymphocytes in terms of surface markers
since both of them express OKT-3, OKT-8, Leu-1 and 4F2 (Grim et
al., 1983) and have no universal markers in comparison to NK
cells. However, the exact relationship between LAK and NK cells
is controversial. At least two different LAK precursors are found
and can be defined by their buoyant density, by their surface
markers and by their susceptible target cells: one that is Thy-1
, Lyt-2~, AGM1+ (i.e., NK-like cell) and one that is Thy-l, Lyt-
2+, AGM1+ (i.e., T-cell-like) (Ballas et ad., 1987). The
biochemical mechanisms that regulate LAK cell activation and the
molecular events that accompany IL-2 stimulation of this process
is not clear. However, the inhibition of adenylate cyclase in
human cells through receptors coupled to the enzyme through G1 or
indirectly via protein kinase C by pharmacologic agents could
potentiate the effect of IL-2 on differentiation of LAK cells as
well as lymphocyte proliferation (Beckner and Farrar, 1988). It
may indicate that cAMP may play a role in regulating LAK
activation.
Adoptive immunotherapy using LAK cells and recombinant IL 2
has been shown to be successful in the treatment of established
pulmonary or hepatic metastases as well as intraperitoneal
tumours in murine models (Eggermont and Sugarbaker, 1987; Ottow
et ad., 1987). Preliminary results of human clinical trials have
also been encouraging (Kimoto and Taguchi, 1987). However,
repeated cycles of IL-2 plus LAK cells showed no additive anti-
tumour effect. It has been suggested that antibodies directed
against absorbed antigens on LAK cells and serum inhibitor of IL-
2 are generated following repeated challenge (Eggermont and
Sugarbaker, 1987).
1.2.5 Specific cytotoxic T cells generated by in vitro
immunization
For adoptive cancer immunotherapy, cytotoxic cells can be
produced massively by co-culturing effector cells with specific
stimulator cells in vitro (Shu et ad., 1986). Although both
allogeneic and syngeneic in vitro immunized lymphocytes are
effective in preventing tumour growth in vivo, the use of
allogeneic cells for adoptive transfer encountered the problems
that they will be eliminated by the host immune defense system
due to different MHC complex. Therefore, syngeneic lymphoid
cells from normal (Kedar et ad., 1978; Mokyr et ad., 1978),
tumour-immune (Cheever et a_l., 1977, 1978; Fernandez-Cruz et ad.,
1979), or tumour-bearing (Mokr et ad., 1978; 1979) animals have
been studied for their ability to generate tumour-specfic
cytotoxicity by in vitro immunization techniques. These studies
demonstrated that although in vitro immunized spleen cells from
normal animals were able to suppress tumour growth in vivo in the
local adoptive transfer assay, they had only little effect when
administered systemically to animals just prior to or shortly
after the injection of tumour cells( Bernstein, 1977; Burton and
Warner, 1977). On the other hand, in vitro immunized spleen
cells from tumour-immune animals were able to suppress tumour
growth both in the local adoptive transfer assay and when
administered systemically to animals prior to the injection of
tumour cells or 1 day following the injection of tumour cells.
In order to enhance the cytotoxicity of specific killer
cells generated by in vitro immunization techniques, both the
culture conditions and the composition of effector cells can be
modified. The success of an j_n vitro immunization culture
depends on: 1. the presence of 1 x 10 to 1 x 10 M 2-ME; 2. the
presence of an appropriate percentage of macrophages; 3. the use
of an appropriate batch of foetal calf serum; 4. a suitable ratio
of responder-to-stimulator cells; 5. an appropriate duration of
culture; 6. an appropriate density of lymphoid cells and
stimulator cells;, and 7. the selection of an appropriate dose of
irradiation or drugs used to inactivate the stimulator cells.
Moreover, the anti-tumour cytotoxicity upon in vitro
immunization can also be augmented by modifying the composition
of effector cells. These include: 1. increasing the frequency
of cytotoxic T lymphocyte precursors (Wagner et ad., 1972;
1973); 2. removal of suppressor cells. The methods used for
removal of the suppressor elements depend on their naiture.
Suppression by T cells may be eliminated either by the use of
anti-I-J serum in vitro or by treatment of spleen cell donors
with cyclophosphamide (CY) in vivo. On the other hand,
suppression by macrophages can be eliminated either by glass
adherence or by inactivation of macrophages with indomethacin,
silica or carrageenan. Other methods include: 1. administering
immunostimulants such as BCG to spleen cell donors; 2. adding
immunostimulants such as BCG, Con A or interleukin 2 to the
culture media and finally 3. increasing the immunogenicity of
stimulator tumour cells by chemical or enzymatic modifications.
There are many advantages of utilizing in vitro immunized
lymphoid cells compared to in vivo immunized cells. These
include: 1. much higher anti-tumour cytotoxicity of effector
cells can be generated; 2. weakly immunogenic tumours can be
used to induce higher level of cell-mediated cytotoxicity; 3. the
risks of injecting malignant cells into the host can be avoided
and 4. a more rapid generation of cytotoxicity occurs.
Moreover, the effectiveness of adoptively transferred in
vitro immunized lymphocytes for the therapy of tumour bearers has
previously been restricted by the limited numbers of cytotoxic
cells that are available. With the establishment of cultures of
cytotoxic cells that continuously proliferate in vitro in the
presence of IL-2, the cytotoxic cells could then be administered
repeatedly in large numbers and thereby might increase the
potential effectiveness of adoptive immunotherapy. In addition,
specific cytotoxic T cells which only lyse those tumour cells
carrying a specific antigen can be selected and propagated due to
the development of T-cell cloning technigues. Therefore, highly
specific cytotoxic T cells which can only recognize a certain
antigen on the tumour cell surface can be generated and used for
adoptive immunotherapy.
1. 3 Mechanisms of cell-mediated cytotoxicity
Cell-mediated cytotoxicity is an important defence mechanism
against proliferation of tumour cells and other foreign agents.
However, the lytic mechanism of cytotoxic lymphocytes is not
clear yet. Recent studies showed that insertion of functional
pores into target cell membrane may be involved in CTL and NK
cell-mediated killing (Young and Cohn, 1986). According to this
view, killing can be divided into four discrete events: 1.
receptor-mediated binding which involves recognition of the
target cell and interaction of effector and target cell surface;
2. polarization of Golgi apparatus, cytoplasmic granules, and
other cytoskeletal elements towards the target cell; 3.
exocytosis of granules and release of a pore-forming protein
(PFP) called perforincytolysin into the intercellular space; 4.
Ca++ -dependent assembly of membrane lesions by polymerization of
PFP in the membrane. The net result is cell death due to
colloidal osmotic lysis.
This model reguires for a directed and localized
degranu1ation of PFP into the contact zone between the effector
and target cells. This is supported by the following observations
• unidirectionality of the killing process was seen sucii that
a CTL could lyse only one target cell at a time even though
several target cells were bound to it (Zargury et ad., 1979); 2.
extensive apposition of plasma membranes occurred in the form of
a network of membrane interdigitations at the sites of cell
contact (Rosenau et ad., 1981); 3. a rapid cytoplasmic
reorientation of the granules, microtubule organizing center and
Golgi apparatus occurred following effector-target conjugate
formation (Kupfer and Dennert, 1984) but not observed when CTL
were bound to nonlysable targets. In addition, fusion of
granules directly with plasma membranes can be monitored
continuously by high-resolution cinemicroscopic studies (Yannelli
et al., 1986). Similar observations have been observed for NK-
mediated killing and ADCC.
Moreover, many CTL and NK cells are found to contain
electron-dense granules in their cytoplasm, commonly observed on
the trans side of the Golgi (Henkart, 1985; Podack, 1985).
Granules isolated from these cells lyse tumour targets
nonspecifically and produce circular lesions with an internal
diameter of 160 A on the target cell membrane. The lytic protein
responsible for these lesions has recently been purified and
termed as pore-forming protein or perforincytolysin. It
migrates on SDS-gels with a molecular mass of 70-75 kD (under
reducing conditions) or 60-66 kD (under nonreducing conditions)
(Masson and Tschopp, 1985; Podack et al., 1985; Henkart et al.,
1986). The ability of perforin to form functional pores in target
membranes was definitely demonstrated through reconstitution
experiments (Young et al., 1987). PFP can depolarize the membrane
of cultured cells and tumour cells nonspecifically. In the
presence of Ca++, PFP polymerizes into supramolecular tubules
with molecular mass 10 daltons on the cell membrane and thus
cause cell death. These tubules resist dissociation by SDS
and reducing agents (Young et al., 1986).
What triggers the secretion of PFP is not yet clear. Calcium
ionophores stimulate degranulation of CTL and NK cells may
indicate that increase of cytosolic Ca++ levels may trigger
secretion. A localized release of PFP into the contact zone may
contribute to the formation of a tightly sealed and diffusion-
limited microenvironment. However, how the CTL and NK cells can
avoid self-lysis remains obscure. It has been proposed that a
surface protein (protectin?) which can neutralize PFP rapidly may
be present on the effector cell membrane (Young et al., 1988).
However, since there are other lytic mechanisms involved in cell-
mediated killing, other protection mechanisms may also be
present.
On the other hand, there are evidence against
perforincytolysin as a primary mechanism (Clark, 1988). Firstly,
cytolytic granules, perforin or serine esterases are not detected
in freshly harvested peritoneal exudate lymphocytes and no
complement-like ring structures are found on lysed target cell
membranes (Berke and Rosen, 1987). Only when these cells are
cmtured with IL —2 for 72 hrs, perforin and serine esterase can
be detected in them. Secondly, it is well known that perforin or
cytolysin has an absolute requirement for Ca44 for assembly and
function (Henkart et al., 1984; Podack et al., 1985). However,it
has been found that certain target cells can be killed by primary
CTL and cloned CTL in the absence of Ca++ (Tirosh and Berke,
1985; Ostergaard et al., 1987; Trem et ad., 1987). This was also
seen in lectin-mediated lysis and in CTL-mediated lysis induced
by phorbol esters and calcium ionophores. Moreover, some cell
lines used as sources for cytotoxic granules and perforin can
kill target cells extremely well in the complete absence o-f Ca4+.
Thirdly, among those antigen-stimulated, IL-2 supplemented CTL
clones that have antigen specificity, only a minority contain
detectable perforin but they are more or less equally cytolytic
and all contain the slower acting, Ca++ -independent TNF-like
soluble toxin activity that is probably granule-associated( Liu
et ad., 1987). Therefore, perforincytolysin may not be a central
component in cell-mediated lysis and other killing mechanisms
may be involved.
In addition to PFP, there are several other lytic mediators
that may have a direct role in cell killing (Marx, 1986; Henkart
et a_l; 1985; Young and Cohn, 1987). These include: 1. reactive
oxygen metabolism intermediates generated by neutrophils and
macrophages during oxidative injury of target cells. Moreover,
hydroxyl radicals, presumably produced in the lipooxygenase
pathway of fatty acid metabolism, may be involved in NK—related
reactions; 2. lymphotoxin and tumour necrosis factor produced by
lymphocytes and macrophages; 3. serine proteases generated in NK
cells and CTL have also been implicated in cytotoxicity; 4. the
28 kD serine esterases which are located in cytoplasmic granules
of CTL and NK cells may also be released during cell killing
(Pasternak and Eison, 1985); 5. leukoregulin which is a
lymphokine secreted by NK cells that predominantly plays a
cytostatic function on a variety of tumour cell lines; 6.
leukalexin with a molecular weight of 50,000 (in reducing form)
is found abundantly in the granules of CTL and can lyse a variety
of targets including TNF and lymphotoxin-insensitive target cells
(Liu et ad., 1987). 7. NKCF which is released into the medium by
mouse and human lymphocytes after contact with tumour cells or
mitogens can kill a variety of NK-sensitive target cells
(Bonavida, 1987). In addition, there are various killer molecules
still to be defined and classified in terms of their roles of
cell killing and thus will not be mentioned here (Green et ad.,
1986; Schmid et a_l., 1986; Liu et ad., 1987).
It is interesting that different lytic molecules may be
bound to the highly negatively charged proteoglycans that have
been found in NK cell granules (MacDernott et ad., 1985; Tschopp
and Conzelmann, 1986). PFP might function as transmembrane
channels for other lytic toxins and enzymes. The permeation of
other toxic molecules of granule origin( serine esterases,
nucleases? or lymphotoxin?) through the membrane might explain
the early disintegration of the target cell nucleus and
fragmentation of target DNA that is observed during target cell
killing by CTL (Russell, 1983; Howell and Martz, 1988).
In conclusion, our understanding on the biochemical
mechanisms of lymphocyte-mediated killing is still in its
infancy. Undoubtedly recent findings have suggested that this
type of killing is rather complex, probably involving multiple
mechanisms as well as multiple mediators. With the availability
of large quantities of defined and cloned cell populations and
the development of subtractive cDNA cloning techniques, it is
hoped that these will eventually provide us with better insight
into the molecular mechanisms underlying cell-mediated
cytotoxicity.
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Inbred C57BL6J(H-2b )mice, and guinea pigs were bred at the
University Animal House, The Chinese University of Hong Kong. In
each experiment, animals of the same age (8-12 weeks old) and
sex were used.
Anti-Thy 1.2 Antibody
Monoclonal anti-Thy 1.2 antibody (F7D5) was purchased from
Serotec Co., U.K. It was dissolved in sterile double distilled
water (DDW) and stored as 0.2 ml aliquots at -70°C before use.
Calcium Ionophore A23187
Calcium ionophore A23187 was purchased from Sigma Chem. Co.,
U.S.A. Stock solution was prepared as 5 mM with dimethylsulfoxide
(DMSO) and stored at -20°C as 0.1 ml aliquots. It was protected
from light by wrapping the vials with tin foil.
Calf Serum
Calf serum obtained from Gibco, U.S.A. was stored at -2 0 C
as 10 and 20 ml aliquots.
Cell Lines
Several murine cell lines including EL-4(H-2b), MBL-2(H-2b),
P815-X2 (H-2d), WEHI-3 (H-2d) and YAC-1 (H-f) were used in this
study. All these cell lines were maintained mainly in suspension
culture in RPMI medium supplemented with 10% foetal calf
serum(FCS) and containing antibiotics (100 unitsml of penicillin
G, lOOugml of streptomycin sulfate and 3 ugml of fungizone).
EL-4 was obtained from the Department of Parasitology,
National Institute for Medical Research, London. It is a
benzopyrene-induced T cell lymphoma of C57BL6J mice and was used
for the large scale production of interleukin-2 in vitro.
MBL-2 tumour is a Moloney leukemia virus-induced T-cell
lymphoma of C57BL6J mice and was the major tumour model used. It
was maintained in vitro in suspension culture and in_ vivo by
weekly intraperitoneal (i.p.) passage in syngeneic C57BL6J mice.
P815-X2 is a methylcholantrene-induced mastocytoma of DBA2
mice and was used as a NK-insensitive tumour target in cytotoxic
assay.
WEHI-3 cell line was a generous gift from Dr. A.A.Nash,
Department of Pathology, University of Cambridge. It is a
myelomonocytic leukemia cell line that was originally derived
from a BALBc mouse.
YAC-1 is a Moloney virus-induced T-cell lymphoma of ASn
mice and was used as a tumour target in natural killer cell
assay.
Complement
Guinea pig serum provides a source of complement. Blood of
anaesthetized guinea pig was collected by cardiac puncture with a
10 ml syringe fitted with a 19G needle. Whole blood was
immediately allowed to clot by standing at 4 C for 3 hrs. Clear
serum was collected without disturbing the clot. The serum was
freed of red cells and debris by centrifugation. In order to
remove the autoantibodies against C57BL6J splenocytes in serum,
the serum was incubated with excess C57BL6J splenocytes at 4 °C
for 30 mins. After removal of splenocytes by centrifugation, the
serum was stored at -20 °C as 1 ml aliquots. Each batch of serum
was tested for complement activity before use in experiments.
Ficol1-1sopague Solution
Ficoll 400 was purchased from Pharmacia Fine Chemicals,
Sweden and metrizoic acid was obtained from Sigma Chem. Co.,
U.S.A.. 14 g of Ficoll 400 was dissolved in 100 ml DDW (14%,
wv) and stirred overnight. Ficoll solution was autoclaved and
kept at 4 °C. 30 ml of metrizoic acid was mixed with 70 ml of
Ficoll 400 solution and the mixture was protected from light by
wrapping the bottle with tin foil. This solution was stored at
4 °C and warmed up to room temperature just before use.
CaClg Solution
CaCl2 was obtained from Sigma Chem. Co., U.S.A.. Stock
solution was prepared as 1 M with DDW and stored at 4 °C before
use.
Cyclophosphamide
Cyclophosphamide was obtained from Sigma Chem. Co., U.S.A..
Stock solution was prepared as 10 mgml with normal saline and
stored at -20 °C before use.
Ethylene glycol- bis( beta-aminoethy1 ether)- N,N,N',N'- tetra
acetic Acid (EGTA)
EGTA was obtained from Sigma Chem. Co., U.S.A.. Stock
solution was prepared as 100 mM with DDW and stored at 4 °C before
use.
Foetal Calf Serum
Foetal calf serum was obtained from Gibco, U.S.A. and was
stored as 10 and 20 ml aliquots at -20 °C until use. Heat
inactivated FCS (HIFCS) was prepared by incubating the aliquots
at 56 °C for 30 mins. FCS was usually used as a supplement to RPMI
medium for cell culture and the final concentration was normally
10%. HIFCS, on the other hand, was used as a serum supplement
for cytotoxicity assays.
1-(5-Isoguinolinyl sulfony1)-2-methylpiperazine (H7)
H7 was obtained from Sigma Chem. Co., U.S.A.. Stock solution
was prepared as 1 mM with plain RPMI medium and stored as 1 ml
aliquots at -2 0 °C before use. It was protected from light by
wrapping the vials with tin foil.
Lectins
Lectins used in the in vitro cultures include concanavalin A
(Con A), phytohaemagglutinin(PHA) and succinyl-concanavalin A
(sCon A). They were obtained from the Sigma Chem. Co., U.S.A..
Stock solutions( 1 mgml) in sterile PBS were sterilized by
millipore filtration and kept as 0.5 ml aliquots at -20 C.
2-Mercaptoethanol Solution
A 0.1 M stock solution of 2-mercaptoethanol(Sigma Chem. Co.,
U.S.A.) was prepared with sterilized plain RPMI medium and kept
at -2 0 °C in 0.5 ml aliquots.
oc-Me thy 1-D-manno side
a-methy1-D-mannoside was obtained from Sigma Chem. Co.,
U.S.A.. Stock solution was prepared as 200 mgml with plain RPMI
medium and stored at 4 C before use.
MgS04 was obtained from Sigma Chem. Co., U.S.A.. Stock
solution was prepared as 1 M with DDW and stored at 4 C before
use.
Mitomycin C Solution
Mitomycin C( from Streptomyces caespitosus, Sigma Chem.
Co., U.S.A.) was dissolved in sterile RPMI medium with a final
concentration of 0.5 mgml. It was protected from light by
wrapping the vial with tin foil and stored at 4 °C.
Neomycin
Neomycin was obtained from Sigma Chem. Co., U.S.A.. Suock
solution was prepared as 100 mM with plain RPMI medium and was
stored as 1 ml aliquots at -20 °C before use.
Nylon Wool Column
Nylon wool was a gift from Dr. D.Y. Sia, Medical Research
Council, Cambridge, U.K.. About 1 g of nylon wool was packed into
a 20 ml glass syringe and then wrapped with tin foil before use.
It was sterilized by autoclaving at 121°C for 30 mins.
Penicil1in-Streptomycin-Fungizone Solution
Penicillin-streptomycin-fungizone solution (PSF) was
purchased from Gibco, U.S.A. and contained 10,000 unitsml of
penicillin G, 10,000 ugml of streptomycin sulfate and 300 ugml
of amphotericin B. This stock solution was stored at -20 °C in 5
ml aliquots. Generally, complete RPMI culture medium was
supplemented with 10% FCS and 1% PSF.
Phorbol Myristate Acetate (PMA)
PMA was purchased from Sigma Chem. Co.,U.S.A.. It was
dissolved in DMSO at a concentration of 5 mgml and stored as
0.2 ml aliquots at -20°C before use. PMA was protected from light
by wrapping the vials with tin foil.
Phosphate-buffered-saline(PBS)
PBS was prepared by dissolving 8.0 g NaCl, 0.2 g KC1, 1.15 g
Na2HP04 and 0.2 g KH2P04 in 1000 ml DDW. The pH of the solution
was adjusted to 7.2-7.4 and the solution was sterilized by
autoclaving at 121 °C for 15 mins.
Polyinosinic-Polycytidy1ic Acid (poly I:C)
Poly I:C purchased from Sigma Chem. Co., U.S.A. was
dissolved in PBS as 1 mgml and kept at 4 C. Each mouse was
injected with 0.1 ml (100 ugmouse) intravenously (i.v.) 24 hrs
before its splenocytes were assay for cytotoxicity on tumoui
targets.
RPMI-1640 Medium
RPMI-1640 powder (Sigma Chem. Co., U.S.A. and Gibco, U.S.A.
for 1 litre preparation was dissolved in 1 litre of DDW am
supplemented with 2.0g NaHC03 and 4.766 g Hepes(Sigma Chem. Co.
U.S.A.). The medium was adjusted to pH 7.2- 7.4 and sterilize
by membrane filtration.
Scinti1lant
Scintillant was prepared by mixing 0.01% (wv) dimethy1-1,4-
bis(2-(5-phenyloxazol)) benzene (POPOP) and 0.4% (wv) 2,5-
diphenyloxazole (PPO) in toluene (Fisher) and was stirred
overnight before use.
Sodium Chromate (Na2 51CrQ4) Solution
Na251Cr04 solution (350-600 mCimg chromium) was purchased
from Amersham, U.K.. Working solution was diluted to about 4
mCiml with sterilized RPMI medium supplemented with antibiotics.
For maximum labelling, 200 pCi 51Cr was added to 5 x 106 cells in
a total volume of 0.4 ml and incubated at 37 °C for 1 hr with
occassional gentle shaking.
(Methyl-3H) Thymidine (3H-TdR) Solution
(Methy-3H) Thymidine (2 Cimmol) was purchased from
Amersham Co., U.K.. 0.5 pCiul working solution was prepared by
diluting the stock solution with sterilized PBS. For pulse
labelling, 0.5 pi working solution was added to each culture
we 11.
Trypan Blue Solution
0.1%(wv) Trypan blue (Sigma Chem. Co., U.S.A.) in PBS was
used to assess the viability of cells.
N-(6-aminohexy1)-5-chloro-l-naphthalene-sulfonamide (W7)
W7 was obtained from Sigma Chem. Co., U.S.A.. Stock solution
was prepared as 10 mgml with DMSO and stored as 0.2 ml aliquots
at -20°C before use.
II.METHODS
Cell Preparation and Isolation:
Spleen Cells
Spleens from groups of 3-4 mice were removed aseptically,
minced with a pair of scissors and pressed through a sterilized
60 mesh stainless steel screen with the plunger of a plastic 5 ml
syringe. Large cell clumps and debris were removed by
centrifuging at 300x g for 5 seconds. The cell suspension was
then spun at 300x g and washed twice with plain RPMI medium.
Single cells were resuspended in complete RPMI medium and kept at
4 °C. Viability of the cell suspension was determined by the
trypan blue dye exclusion method( Philip, 1973) and usually was
found to be greater than 90%.
Depletion of T Cells by Anti-Thy 1.2 Antibody and Complement
Treatment
Monoclonal anti-Thy 1.2 antibody was added to spleen cell
suspension( 2 x 10 cellsml) at a final dilution of 1: 1000.
The mixture was then incubated at room temperature for 30 mins.
The cells were spun down and resuspended at the same
concentration with appropriately diluted guinea pig complement
(usually diluted 1: 10 with serum-free medium). After 45 min
incubation at 37 °C, cells were washed with plain RPMI medium for
three times and then adjusted to the desired cell concentration
in RPMI medium supplemented with 10% HIFCS and PSF.
T Cell Enrichment by Nylon wool Column
First, the nylon wool column was thoroughly rinsed with 50
ml prewarmed plain RPMI medium. Then the nylon wool was covered
with RPMI medium supplemented with 10% HIFCS and the column was
freed of air bubbles by agitation with a pipette. The nylon wool
column was then incubated at 37°C for 1 hr. Meanwhile, splenocyte
suspension was prepared at a concentration of 10 cellsml and
prewarmed up to 37°C. Just before adding the cell suspension,
the nylon wool column was rinsed with 5-10 ml of prewarmed medium
and then allowed to run dry. 2 ml of cell suspension was added
and allowed to penetrate the column. An additional 0.5ml complete
medium was added so as to cover the entire nylon wool column.
Then the column was closed and incubated at 37°C for 1 hr.
Nylon wool nonadherent cells( enriched for T cells) can be
collected into a 50 ml centrifuge tube by washing the column with
40-50 ml prewarmed medium supplemented with 5% HIFCS. The
flow rate was 1 drop per second. The cells were spun down at 300x
g for 5 mins and then resuspended in RPMI medium supplemented
with 10% HIFCS
Nylon wool adherent cells (consisted of mainly B cells and
macrophages) can also be collected. After removal of T ells,
the nylon wool column was cooled to 4 C and cold plain RPMI
medium was then added to the column. Adherent cells can be
recovered by pushing the fluid forcibly out of the column with a
plunger.
Mitomycin C Treatment of Cells
Splenocytes( 5 x 107 ml) or tumour cells (5 x 106 ml) were
prepared in complete RPMI medium (RPMI+ 10% FCS). Mitomycin C
was added to the cell suspension at a final concentration of 50
pgml. The mixture was incubated for 30 mins at 37 °C with
occassional shaking. Cells were washed three times with plain
RPMI medium before use.
Determination of Splenocyte Cytotoxicity
Cytotoxicity assays were carried out in triplicates using
96-well flat-bottomed microtiter plates(Nunc, Denmark). The total
volume of each well was 200 ul. Normal splenocytes were used as
effector cells. Tumour targets were labelled with 200 uCi
Na2 Cr04 for 1 hr at 37 C with occassional gentle shaking. The
cells were then washed two times with plain RPMI medium and
adjusted to 2-4 x 10 cellsml in RPMI medium supplemented with
10% HIFCS and PSF. Effector:target cell ratios of 50:1 and 100:1
were always used. The assays were incubated at 37 °C in a
humidified atmosphere of 5% C02 in air. After a certain period
of incubation, 100 ul supernatant was carefully sucked up from
each well and its radioactivity was counted in a Beckman gamma
counter. For spontaneous release, 0.1 ml RPMI medium supplemented
with 10% HIFCS and PSF in the absence or presence of lectins or
drugs was added to 0.1 ml labelled target cells. For maximum
re leasable 51Cr, 0.1 ml 10% triton-XlOO was added to 0.1 ml
labelled target cells. For the test release, effector cells were
added to labelled target cells in the absence or presence of
lectins or drugs to make up to a final volume of 0.? ml. The
51
percentage Cr release was calculated by the following formula:




M: Maximum releasable counts
S: Spontaneous release count'
T: Test release counts
Ficol1-Isopague Gradient Centrifugation
This procedure removes both red blood cells and dead cells
from viable lymphocytes in a single step with high efficiency.
Briefly, cell suspension and Ficol1-Isopaque solution were
prewarmed to room temperature in a water bath. 4 ml of Ficoll-
Isopaque solution was added to a polycarbonate tube and 2-6 ml of
the cell suspension was gently layered on top of the Ficoll-
Isopaque solution. The tube was centrifuged at 2000x g for 15
mins at room temperature. Viable cells were collected by
harvesting the interphase cell layer. The cells were washed three
times with RPMI medium before use.
In Vivo Immunization of Mice with Mitomycin C-Treated Tumour
Ce 1 Is
Primary immune splenocytes were obtained from C57BL6J mice
7 days after intravenous injection with 10? mitomycin C-treated
MBL-2 cells. Similarly, secondary immune splenocytes were
obtained from C57BL6J mice immunized twice with mitomycin C-
treated MBL— 2 cells. The second immunization was done at 1 e a o t
20 days after the first immunization and the cells were harvested
3 days after the second injection of tumour cells.
Mixed Lymphocyte Tumour Culture
Totally 1.2 x 10 normal or immune C57 BL6J
splenocytes were co-cultured with 6 x 10 mitomycin C-treated
MBL-2 tumour cells in 50 ml RPMI medium supplemented with 10%
FCS and 5 x 10 M 2-mercaptoethanol (2-ME) and the cell mixtures
were incubated at 37°C in a humidified atmosphere of 5% C02 in
air. After 5 day incubation, effector cells were harvested and
dead cells were removed by Fico 11-Isopaque gradient
centrifugation. The cytotoxicity of the effector cells generated
was measured by the standard Cr-release assay using MBL-2,
P815 and EL-4 cells as targets. Effector:target ratios of 10:1
and 20:1 were normally used and the incubation time was 8 hrs.
Production of Interleukin-2
Large scale production of interleukin-2 (IL-2) was achieved
by in vitro stimulation of EL-4 cells with PMA (Farrar et a 1.,
1980). 4 x 107 EL-4 cells were cultured with 4 pg PMA in 40 ml
RPMI medium supplemented with 2% FCS and incubated at 37°C in 5%
C02 for 6 hrs. After two washings, the cells were resuspended in
40 ml RPMI medium containing 5% FCS and incubated for a further
period of 24 hrs. Cells were then pelleted by centrifugation at
300x g for 5 mins and the supernatant was harvested and stored at
-20 °C as 10 and 20 ml aliquots. IL-2 activity of the supernatant
was measured by using the IL-2 assay as described by Lafferty
et al.(1980).
Proliferative Response of In Vitro Cultured Lymphocytes
After 5 days of ijn vitro mixed lymphocyte tumour culture, a
portion of the viable cells was collected and further cultured in
RPMI medium supplemented with 10% FCS and 5 x 10 M 2-ME for 2
days. Then the cells were harvested and dead cells were removed
by Ficol1-Isopaque gradient centrifugation. The cell suspensions
were adjusted to a final concentration of 10 cellsml.
Mitomycin C-treated tumour cells were used as stimulators and
adjusted to a concentration of 2 x 10 cellsml. 50 ul cells
and 50 ul stimulators were added to each well of a 96-well
microtiter plate. 100 ul complete RPMI medium supplemented with
5 x 10 M 2-ME and containing no IL-2 or 10% IL-2 was added to
each well. The stimulators used included the MBL-2, P815 and
EL-4 cells. After 48 hr incubation at 37°C in a humidified
atmosphere of 5% C02 in air, the cultures were pulsed with 0.5
uCi 3H-TdR for 16 hrs before harvesting onto glass fibre filter
using a Titertek multi-harvester (Flow Lab. Ltd.,U.K.).
Incorporated H-TdR label was counted in a Beckman scintillation
counter (Beckman LS1801, U.S.A.) and the results were expressed
as counts per minute (CPM).
Statistical Analysis
All results were expressed as the arithmetic mean+ standard
error (S.E.). Student's' t'test was used to determine the
confidence limits in group comparison. Normally p=0.05 was
regarded as significant difference.
CHAPTER THREE: INDUCTION OF NONSPECIFIC LYMPHOCYTE-MEDIATED












Dose response of lectin-induced lymphocyte-mediated
cytotoxicity against tumours
Time course of lectin-induced lymphocyte-mediated
cytotoxicity against tumours
The induction of lymphocyte-mediated cytotoxicity against
various tumour targets by lectins
Time course of Con A-induced lymphocyte-mediated
cytotoxicity against tumours: Comparison of normal and
poly I:C activated splenocytes
Induction of lymphocyte-mediated cytotoxicity against
tumours by Con A: Comparison of normal and MMC-treated
splenocytes
Determination of the cell type that is responsible for
the induction of lymphocyte-mediated cytotoxicity by
lectins
Effect of T-cell enrichment by nylon wool column on
lectin-induced lymphocyte-mediated cytotoxicity
Effect of pretreatment of effector cells andor target
cells with lectins on the induction of lymphocyte-





The effect of temperature on the induction of
lymphocyte-mediated cytotoxicity against tumours by
lectins
Inhibition of lectin-induced lymphocyte-mediated
cytotoxicity by a-methy1-D-mannoside
The requirement of divalent metal ions on the lectin-
induced lymphocyte-mediated cytotoxicity
The inhibitory effect of various pharmacologic agents on




The study of lectin-dependent ce11-mediated cytotoxicity
(LDCC) was initially based on the observation of Moller (1965).
She and others (Rubens and Henney, 1977; Thierry et al.., 1977;
Tartof and Fitch, 1978; Waterfield et al., 1981; Eugene et al.,
1982) have found that alloimmune spleen cell populations and
concanavalin A (Con A) or phytohemagglutinin (PHA)-activated
splenocytes could kill a wide spectrum of tumour targets,
including those of syngeneic origin, when incubated with Con A or
PHA at the same time. In addition, it was demonstrated that
specific cloned cytotoxic T lymphocytes and even cloned helper T
cells could lyse syngeneic and third party target cells
efficiently in the presence of lectins (Bonavida et al., 1983;
Leung and Nash, 1987). Moreover, some investigators reported
that polymorphonuclear leukocytes were also capable of lysing
various tumour cells in the presence of plant lectins (Clark and
Klebanoff, 1979) or animal lectins( Yamazaki et al., 1983). In
contrast, Tartof (1980) showed that increasing concentrations of
Con A could inhibit the immunologically specific cytotoxic T
lymphocyte-mediated cytolysis. However, all these investigators
did not observe any significant cytolysis of syngeneic or
allogeneic target cells in the presence of lectins when normal,
rather than alloimmune or mitogen-activated spleen cells were
used as the effector cells.
Current work in our laboratory has been focussed on the in
vitro activation and modulation of lymphocyte-mediated
cytotoxicity against syngeneic tumours. In contrast to the
previous reports, the present investigation has shown that under
appropriate conditions, various mitogenic lectins (including PHA,
Con A and its succinylated derivative) were found to be capable
of inducing normal mouse splenocytes to lyse various tumour
targets. In addition, this lectin-induced cytolysis of tumour
targets was found to be T eel 1-mediated and calcium- and
temperature-dependent.
RESULTS
3.1 Dose response of lectin-induced lymphocyte-mediated
cytotoxicity against tumours:
In order to determine whether mitogenic lectins can induce
normal splenocytes to lyse various tumour targets in vitro, three
plant lectins( Con A, succinyl Con A, PHA) were chosen' for the
present study. Normal splenocytes from C57 BL6J mice (H-2)
were incubated with Cr-labelled allogeneic YAC-1 cells (H-2)
or similarly labelled syngeneic MBL-2 cells (H-2) for 6 and 10
hrs respectively in the presence of various concentrations of
lectins and the specific lysis of the these two tumour targets
was determined.
As shown in Fig. 3.1, it can be seen that Con A could induce
significant splenocyte cytotoxicity against the two tumour
targets in a dose—dependent manner. The optimal concentration of
Con A for the induction of LDCC was found to be 3-6 ugml. At
higher concentrations Con A exhibited diminished ability on the
induction of LDCC, so Con A at a concentration of 6 pgml was
chosen for subseguent experiments. In contrast, sCon A did not
show diminished ability on induction of LDCC at higher
concentrations. In fact, sCon A induced splenocyte cytotoxicity
increased with increasing concentrations of sCon A up to a
concentration of 12 ggml. Therefore, for direct comparison lO
the LDCC induced by that of Con A, sCon A at a concentration of 6
pgml was deliberately chosen for further studies.
Similarly, PHA was also found to be effective in mediating
LDCC although it was much less potent than that of Con A and
sCon A (Fig. 3.2). The optimal concentration of PHA for the
induction of LDCC were found to be 2.5 jigml for YAC-1 target and
10 ]jgml for MBL-2 target.
It should be noted that the spontaneous 51Cr release from
the two tumour targets was not significantly different in the
absence and in the presence of lectins at all concentrations used
in our experiments in a 6 hr (YAC-1) or 10 hr (MBL-2) 51Cr-
release assay (data not shown). Thus, the three plant lectins,
when present alone, are not toxic to the two tumour targets under
the prescribed experimental conditions. Since Con A and sCon A
are much more potent than PHA for the induction of LDCC against
the two tumour targets, these two lectins will be primarily used
in further studies.
3.2 Time course of lectin-induced lymphocyte-mediated
cytotoxicity against tumours
In order to determine the best incubation time for inducing
maximum lysis of the two tumour targets, normal splenocytes from
C57BL6J were incubated with 5Cr-labelled tumour targets
(YAC-1 and MBL-2 cells) in the absence or presence of Con A and
sCon A (6 pgml) for various time periods (2-12 hrs). It was
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Figure 3.1 Dose response of Con A-induced lymphocyte-mediated
cytotoxicity on YAC-1 and MBL-2 targets as compared to that
induced by succinyl Con A (sCon A). Normal mouse splenocytes were
incubated with 51Cr-labelled YAC-1 (a) and MBL-2(b) tumour
target cells at an E:T ratio of 100:1 in the presence of
various concentrations of Con A( - ) or sCon A( - )
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Figure 3.2 Dose response of PHA-induced lymphocyte-mediated
cytotoxicity against tumours. Normal mouse splenocytes were
incubated with Cr-labelled YAC-1 (a) and MBL-2 (b) tumour target
cells at an E:T ratio of 100:1 in the presence of the various
concentrations of PHA in a 6 hr (a) and 10 hr (b) 51Cr-release
assay.
with time with both tumour targets (Fig. 3.3 and Fig. 3.4). With
YAC-1 target, the greatest difference in the percentage lysis
between the control and lectin-treated groups reached a plateau
at about 6 hrs of incubation whereas the percentage of lectin-
dependent cytolysis on MBL-2 target was maximal at about 10-12
hrs. Therefore, in subsequent experiments, a 6 hr 51Cr-release
assay was used for YAC-1 cells whereas a 10 hr 51Cr-release assay
was used for MBL-2 cells.
3.3 The induction of lymphocyte-mediated cytotoxicity against
various tumour targets by lectins
From the previous experiments, it was shown that both Con A
and sCon A could induce significant splenocyte cytotoxicity
against YAC-1 and MBL-2 tumour targets. It raises the question
as whether these lectins can also induce similar LDCC against
other tumour targets. Results in Table 3.1 and 3.2 showed that
both Con A and sCon A could also induce normal C57 BL6J mouse
splenocytes( H-2b) to kill various syngeneic and allogeneic
tumour targets, including P815 (H-2d), WEHI-3 (H-2d) and EL-4
(H-2b) cells, in a 10 hr 51Cr release assay. It was found that
different tumour target cells showed different susceptibility to
lectin-induced cytolysis. In general, the YAC-1 and MBL-2 tumour
cells were found to be good targets for LDCC whereas the P815 and
WEHI-3 cells were of intermediate sensitivity to LDCC. The EL-4
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Figure 3.3 Time course of Con A-induced lymphocyte-
mediated cytotoxicity against tumours. Normal mouse splenocytes
were incubated with 51Cr-label led YAC-l(a) and MBL-2(b) tumour
target cells at an E:T ratio of 100:1 in the absence( - ) or
presence( - ) of Con A (6 jjgml). The percentage lysis was
determined every 2 hrs for 12 hrs. The difference between the
percentage lysis of tumour target in the presence and absence of
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Figure 3.4 Time course of succiny1 Con A-induced lymphocyte-
medidated cytotoxicity against tumours. Normal mouse splenocytes
were incubated with 51Cr-laoe1 led YAC-1 (a) and MBL-2 (b) tumour
target cells at an E:T ratio of 100:1 in the absence - ) or
presence ( — ) of sCon A (6 jagml). The percentage lysis was
determined every 2 hrs for 12 hrs. The difference between the
percentage lysis of tumour target in the presence and absence of
sCon A was referred to as the precentage of sCon A-dependent.
cytolysis( ).
Table 3.1 The induction of lymphocyte-mediated cytotoxicity
against various tumours by Con A
Tumour
target E: T@ No Con A
51





































Normal C57 BL6J mouse splenocytes (effector cells) were
incubated with Cr labelled tumour target cells in the absence or
presence of Con A (6 pgml) for 10 hrs.
□ Effector-to-target cell ratio.
Table 3.2 The induction of lymphocyte-mediated cytotoxicity
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Normal mouse splenocytes (effector cells) were incubated with
51 Cr labelled tumour target cells in the absence or presence of
sCon A (6 pgml) for 10 hrs.
□ Effector-to-target cell ratio.
3•4 Time course of Con A-induced lymphocyte-mediated
cytotoxicity against tumours: Comparison of normal and poly I:C
activated splenocytes
In order to study the nature of effector cell populations
activated by lectins, I have compared the normal resting
lymphocytes versus the poly I:C-activated lymphocytes as a source
of effector cells for LDCC. In this experiment, each normal C57
BL6J mouse was injected intravenously (i.v.) with 100 ug
poly I:C whereas the control mice received an intravenous
injection of an equal volume of PBS. After 16-24 hrs,
splenocytes in these two groups of mice were prepared and
incubated with 51Cr-labe1 led tumour target cells in the absence
or presence of an optimal concentration of Con A (6 pgml) for
various time periods.
As shown in Fig. 3.5, the poly I:C-activated splenocytes
displayed slightly higher killing activity on the two tumour
targets as compared to normal resting splenocytes in the absence
of Con A. However, in the presence of Con A, both the kinetic
curves and the percentage of cytotoxicity were very much similar
for poly I:C-activated and normal splenocytes.
3.5 Induction of lymphocyte—mediated cytotoxicity agains t
tumour s by Con A• Comparison of norma 1 and MMC —treated
splenocytes
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Figure 3.5 Time course of Con A-induced lymphocyte-mediated
cytotoxicity against tumours: Comparison of normal and poly I re¬
activated splenocytes. Normal C57 BL6J mice were injected i.v.
with 100 ug poly I:C mouse. After 16-24 hrs, poly I:C-activated
splenocytes were prepared and incubated with 1Cr-labe1 led YAC-1
(a) and MBL-2 (b) target cells at an E:T ratio of 100:1 in the
absence ( - ) or presence ( — ) of Con A (6 jigml)) for various
time periods. As a control, normal splenocytes from mice
injected with PBS were incubated with Cr—labelled tumoui
target cells at an E:T ratio of 100:1 in the absence( - ) or
presence (O— Oi of Con A under identical conditions.
effector cells is required for mediating LDCC, normal mouse
splenocytes were either incubated with complete medium or
pretreated with mitomycin C (MMC) for 1 hr as described in
Materials and Methods so as to inhibit cellular DNA synthesis.
The untreated or MMC-pretreated splenocytes were then incubated
with 51Cr-labe1 led YAC-1 target at various concentrations of Con A
for 6 hrs. Results in Fig. 3.6 showed that similar dose-
response curve of LDCC was given by MMC-pretreated splenocytes
and normal splenocytes. This suggested that proliferation of the
effector cell population was not required for the induction of
LDCC against tumours by Con A.
3.6. Determination of the cell type that is responsible for the
induction of lymphocyte-mediated cytotoxicity by lectins
In order to characterize the nature of effector cell
population (s) that is responsible for mediating LDCC against
tumours, T cells were depleted from normal mouse splenocytes by
treatment with monoclonal anti-Thy 1.2 antibody plus complement
as described in Materials and Methods. The untreated or
complement-treated groups served as the positive controls. These
51
three groups of effector cells were incubated with Cr-labelled
tumour targets in the absence or presence of lectins (Con A
sCon A) for the indicated periods of time. Data from Table 3.3
and 3.4 showed that 1. complement treatment alone did not affect
LDCC against the two tumour targets; 2. depletion of T cells by
treatment with anti-Thy 1.2 and complement completely abrogated
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Figure 3.6 Induction of lymphocyte-mediated cytotoxicity against
YAC-1 target by Con A: Comparison of normal and MMC-pretreated
splenocytes. Normal mouse splenocytes were pretreated with
mitomycin C for 1 hr as described in Materials and Methods.
Normal untreated( ) or MMC-pretreated( -) splenocytes
were incubated with 51Cr-labe1led YAC-1 tumour target cells at
various concentrations of Con A at an E:T ratio of 100:1 in a 6
51
hr Cr-release assay.
Table 3.3 Determination of the cell type that is responsible
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Normal mouse splenocytes were treated with complement only
(C') or with anti-Thy 1.2 antibody plus complement (Ab +C') as
described in Materials and Methods. The C', Ab+ C' and untreated
groups were incubated with Cr labelled tumour target cells in
the absence or presence of Con A (6 pgml) for 6 hrs (YAC-1)
or 10 hrs (MBL-2). The effector-to-target cell ratio was 100:1.
Table 3.4 Determination of the cell type that is responsible
for the induction of lymphocyte-mediated cytotoxicity by sCon A
Tumour
target Group E: T@
51
% Specific Cr release













































Normal splenocytes treated with complement only (C') or with
anti-Thy 1.2 antibody plus complement (Ab+C') as described in
Materials and Methods. The C, Ab+C and untreated groups were
then incubated with 51Cr labelled tumour target cells in the
absence or presence of sCon A (6pgml) for 6 hrs (YAC-1) or 10
hrs (MBL-2).
□ Effector-to-target cell ratio.
lectin induced cytotoxicity is T ce 11-dependent.
3•7 Effect of T cell enrichment by nylon wool column on lectin-
induced lymphocyte-mediated cytotoxicity
To further establish the nature of effector cells involved
in LDCC, normal mouse splenocytes can be enriched for T cells by
fractionation on nylon wool column. It has been known that T
cells (and some null cells) can pass through nylon wool column
while B cells and macrophages are preferentially retained
( Trizio and Cudkowicz, 1974). In this experiment, normal mouse
splenocytes were separated on nylon wool column into nonadherent
and adherent fractions while unfractionated cells served as the
control. As shown in Table 3.5 and 3.6, it can be seen that 1.
the nylon wool nonadherent cells displayed higher killing
activity against MBL-2 tumour target as compared to the control
unfractionated cells in the presence of lectins; 2. the lectin-
dependent cytolysis of MBL-2 tumour target was not seen with the
nylon wool adherent cells. These results, when taken together,
strongly indicate that the main effector cells for LDCC are T
cells.
3.8 Effect of pretreatment of effector cells andor target cells
with lectins on the induction of lymphocyte-mediated cytotoxicity
against tumours
Con A is a lectin which can bind oligosaccharide residues on
Table 3.5 Effect of T cell enrichment by nylon wool column on
Con A-induced lymphocyte-mediated cytotoxicity against MBL-2
tumour target
Tumour
target Group E: T@
_% Specific Cr release






















Normal mouse splenocytes were separated into two cell fractions
on nylon wool column. The nonadherent fraction (NAF) was
consisted' of mainly T cells whereas the adherent fraction (ADF)
was consisted of mainly B cells and macrophages. The
unfractionated cells served as a control. These three cell
fractions were incubated with 51Cr-label led MBL-2 tumour cells for
10 hrs in the absence or presence of Con A (6 pgml).
□ Effector-to-target cell ratio.
Table 3.6 Effect of T cell enrichment by nylon woo1 column on
succinyl Con A-induced lymphocyte-mediated cytotoxicity against
MBL-2 tumour target
Tumour
target Group E:T@ No sCon A













3. 5± 0. 4
4.8 ±1. 0
4 .0+ 0. 0
7. 8± 0. 9
3 4.8 ±0. 2
3 9.9 ±0. 9
4 4.8 ±0. 3
5 3.2 ±0.8
15.6 ±1.0
2 0.4 ±1. 2
Normal mouse splenocytes were separated into two cell fractions
on nylon wool column. The nonadherent fraction (NAF) was
consisted of mainly T cells whereas the adherent fraction (ADF)
was consisted of mainly B cells and macrophages. The
unfractionated cells served as a control. These three fractions
were incubated with 51Cr labelled MBL-2 tumour cells for 10 hrs
in the absence or presence of sCon A (6 pgml).
□ Effector-to-target cell ratio.
t tie q 1 ycoproteins on the surface of cells. It is of interest to
know whether Con A can act either on the effector cells or target
cells alone in order to induce LDCC. Therefore, normal mouse
splenocytes and tumour target cells were pretreated with an
optimal concentration of Con A (6 ugml) for 1 hr at 37°C and
then washed 3 times with plain RPMI medium so as to remove the
excess unbound Con A. As shown in Fig. 3.7(a), Con A pretreatment
of either effector cells or YAC-1 target cells alone induced a
significant but slightly lower level of LDCC as compared to that
of the continuous presence of Con A in the medium. However, when
Con A pretreated effector cells and target cells were mixed
together, it was found that cytolysis of YAC-1 target was similar
to that of the continuous presence of Con A in the medium. In
contrast, Con A pretreatment of effector cells alone induced a
substantial lower level of cytolysis against MBL-2 target cells
when compared to Con A pretreatment of MBL-2 target cells alone
(Fig. 3.7(b)). Moreover, the combination of two resulted in
cytolysis against MBL-2 target cells which was similar when
target cells were pretreated with Con A alone. These findings
would seem to indicate that Con A could bind to either effector
cells or target cells alone to induce cytolysis but the action of
Con A on effector cells was different on different tumour
targets.
In contrast to the previous results of Con A—induced
1ymphocyte—mediated cytotoxicity, it was found that pretreatment
of effector cells andor target cells with sCon A (6 pgml) for 1
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Figure 3.7 Effect of pretreatment of effector cells andor
target cells with Con A on the induction of lymphocyte-mediated
cytotoxicity against tumours. Normal mouse splenocytes and
tumour target cells were pretreated with Con A (6 pgml) for 1 hr
at 37 °C. Con A-pretreated (LL) or normal (NL) spier; :cytes were
incubated with Con A-pretreated (LT) or normal (NT) 51Cr-
labelled tumour target cells at a 50:1 (hatched bar) or 100:1ci
(open bar) E:T ratio in a 6 hr Cr-release assay for YAC-1
target (a) and a 10 hr 51Cr-release assay for MBL-2 target (b).
The control groups vere untreated splenocytes incubated with
untreated 51Cr-label led tumour target cells in the absence or
presence of Con A (6 ugml)(L) under identical conditions.
targets (YAC-1 and MBL-2) (Pig. 3.8).
3.9. The effect of temperature on the induction of lymphocyte-
mediated cytotoxicity against tumours by lectins
In order to study the temperature requirement for induction
of efficient lysis of the targets, normal mouse splenocytes were
incubated with 51Cr-labe 1 led tumour target cells in the absence or
presence of lectins at 37°C, room temperature (22°C) or 4 °C for 6
hrs (YAC-1 tumour target) and 10 hrs (MBL-2 tumour target).
Results in Table 3.7 and 3.8 showed that by cooling the cell
mixture to 4°C or by maintaining the effector and target cells at
room temperature throughout the incubation period, the induction
of lymphocyte-mediated cytotoxicity against tumours by the two
lectins was completely inhibited.
3.10 Inhibition of lectin-induced lymphocyte-media ted
cytotoxicity by a-methy1-D-mannoside
a-methy1-D-mannoside( amMan) and other a-D-g1ucosamine and
mannopyranosides are the most effective oligosaccharide
inhibitors of Con A (Baenziger and Fiete, 1979) and these sugars
can rapidly bind to Con A and remove it from the cell surface. In
order to determine whether the binding of the lectins (Con A,
sCon A) to the cell surface is essential for 'triggering LDCC,
the inhibitory effect of a-methy1-D-mannoside on the lectin-
induced lymphocyte—mediated cytotoxicity was examined. Normal
Figure 3.8 Effect of pretreatment of effector cells andor
target cells with succinyl Con A on the induction of lymphocyte-
mediated cytotoxicity against tumours. Normal mouse splenocytes
and tumour target cells were pretreated with sCon A (6 ugrnl)
for 1 hr at 37°C. sCon A-pretreated (sLL) or normal (NL)
splenocytes were incuba ;ed with sCon A-pretreated (sLT) or normal
(NT) s1Cr-label led tumour target cells at a 50:1 (hatched bar) or
100:1 (open bar) E: T ratio in a 6 hr 5 Cr-release assay for YAC-1
target (a) and a 10 hr 51Cr-release assay for MBL-2 target (b).
The control groups were untreated normal splenocytes incubated
with untreated 51Cr-labe1 led tumour target cells in the absence
or presence of sCon A (6 jjgrnl) (sL) under identical conditions.
Table 3.7 The effect of temperature on the induction of
lymphocyte-mediated cytotoxicity against tumours by Con A
Tumour Incubation
target temperature E: T@
51
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5 5.8 ±1. 6
2.0 ±0. 3











Normal mouse splenocytes were incubated with Cr labelled
tumour target cells in the absence or presence of Con A (6pgml)
for 6 hrs (YAC-1 target) and 10 hrs (MBL-2 target) at the
indicated temperatures in a air-tight box containing 5-6 CC in
air.
□ Effector-to-target cell ratio.
Table 3.8 The effect of temperature on the induction of







ho sCon A With sCon A
YAC-1 3 7 °C
2 2 °C
4 °C


























2. 0± 0. 5
47.7+1.2










1. 0± 0. 2
Normal mouse splenocytes were incubated with Cr labelled
tumour target cells in the absence or presence of sCon A (6pgml)
for 6 hrs (YAC-1 target) and 10 hrs (MBL-2 target) at the
indicated temperatures in an air-tight box containing 5« C02 in
air.
□ Effector-to-target cell ratio.
mouse sp1enocytes were incubated with Cr-labelled tumour target
cells in the absence or presence of lectin (Con A or sCon A).
aniMan was also added at various concentrations and the mixtures
were incubated for the indicated periods of time. As shown in
Fig. 3.9, sCon A-induced cytolysis of the two tumour targets was
readily inhibited by the addition of a very low concentration of
amMan (1.6 mgml). In contrast, a much higher concentration of
amMan (12.5 mgml) was required to inhibit all LDCC induced by
Con A. Therefore, these results indicated that the binding
affinity of amMan for Con A and sCon A may be quite different.
3.11 The requirement of divalent metal ions on lectin-induced
lymphocyte-mediated cytotoxicity
It has been well established that calcium ions play a very
important role on the antigen-specific T ce11-mediated
cytotoxicity( Plaut et ad., 1976). It is of interest to know
whether they are also involved in LDCC. EGTA is a very commonly
used Ca chelator which can be used to deplete extracellular Ca
in the culture medium. In the first set of experiments, normal
mouse splenocytes were incubated with 51Cr-labe1led tumour target
cells in the absence or presence of Con A (6 iigml). EGTA at
various concentrations was also added and the mixtures were
incubated for the indicated periods of time. As shown in Fig.
3mio, it can be seen that EGTA exhibited a dose—dependent
inhibitory effect on the Con A—dependent lymphocyte— mediated
cyto lysis of the two tumour targets. Very little inhibitory
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Figure 3.9 Dose-dependency of a-methy1-D-mannoside on inhibition
of lymphocyte-mediated cytotoxicity induced by Con A and succinyl
Con A. Normal mouse splenocytes were incubated with Cr-labelled
YAC-1 cells (a) and MBL-2 cells (b) in the presence of Con A
(6 ugml)(•-•), sCon A (6 pgml) (O-O) or in the absence of
the two lectins( A-A). amMan was added at the beginning of the
culture at various concentrations, the mixtures were incubated
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Figure 3.10 The effect of depletion of Ca++ by EGTA on Con A-
induced cytolysis. Normal mouse splenocytes were incubated with
5tr-labelled YAC-1 (a) and MBL-2 (b) tumour target cells at an E: T
ratio of 100:1 in the absence( - ) or presence( - ) of Con
A (6 ugml). EGTA at various concentrations was also added and
the mixtures were incubated for 6 hrs(a) and 10 nrs (b).
very significant decrease in the lysis of the tumour targets was
observed at 0.6 mM EGTA concentration whereas 0.8 mM EGTA
virtually abolished (90% inhibition) the Con A-induced cytolysis
of the two tumour targets. Similar results were obtained for the
sCon A-induced lymphocyte-mediated cytotoxicity (Fig. 3.11)
except that the inhibitory effect of EGTA was less drastic on
YAC-1 target (only about 80% inhibition of the sCon A-induced
cytolysis at an EGTA concentration of 0.8 mM). It should be noted
that the endogenous NK activity in YAC-1 target also showed
similar dose-inhibition curves with the addition of EGTA to the
assay system (Fig. 3.10(a) and 3.11 (a)).
It is known that EGTA can chelate other divalent metal ions
as well as Ca. In order to further study the role of Ca and
other divalent metal ions on lectin-induced lymphocyte-mediated
cytolysis of tumour targets, in the second set of experiments, Ca
or Mg were examined for their ability to reverse the inhibitory
effect on LDCC due to metal ion depletion resulting from the
addition of EGTA (0.8mM). It was found that 0.13 mM Ca++ could
significantly reverse the inhibitory effect of EGTA on LDCC
against MBL-2 target and virtually no inhibitory effect of EGTA
was observed at a Caconcentration of 0.25 mM (Fig. 3.12 (a)).
In contrast, Mg were found to be ineffective in reversing the
inhibitory effect of EGTA on LDCC against MBL-2 target even when
present at a concentration as high as 1 mM (Fig 3.12 (b)).
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Figure 3.11 Effect Oi depletion of Ca++by EGTA on succinyl
Con A-induced cytolysis. Normal mouse splenocytes were incubated
with 51Cr-label led YAC-1 (a) and MBL-2 (b) tumour target cells
at an E: T ratio of 100:1 in the absence ( - ) or presence(
of sCon A (6 pgml). EGTA at various concentrations was also
added and the mixtures were incubated for 6 hrs (a) and lOhrs(b).
Figure 3.12 The effect of divalent metal ions on Con A-induced
lymphocyte-mediated cytotoxicity. Normal mouse splenoyctes were
incubated with 51Cr-labe1 led MBL-2 tumour target cells in the
absence( hatched b ir) or presence (open bar) of Con A (6
ugml) at an E:T ratio of 100:1. With the exception of the
control group (C), EGTA was added to the mixtures at a final
concentration of 0.8 mM. Ca (a) and Mg (b) at various
concentrations were then added (except the control group) and the
specific 51Cr-release was determined in a 10 hr assay.
for induction of lymphocyte-mediated cytotoxicity against MBL-2
tumour target (Fig. 3.13). These data, when taken together,
indicate that Ca may play a crucial role on the LDCC against
tumours.
3.12 The inhibitory effect of various pharmacologic agents on
lectin-induced lymphocyte-mediated cytotoxicity against tumours
As a preliminary attempt to elucidate the mechanisms by
which lectins can induce normal splenocytes to lyse a syngeneic
tumour target, several pharmacologic agents were tested for their
ability to inhibit LDCC. The full names and biological
activities of these drugs were listed in Table 3.9. The drugs
at their pre-determined optimal concentrations for inhibiting
lymphocyte proliferation were used in the present study. It was
found that the drugs used at these concentrations were neither
toxic to normal splenocytes nor to the tumour target within 12
hrs (data not shown).
In order to study the effect of various pharmacologic agents
on LDCC, normal C57 BL6J mouse splenocytes were incubated with
syngeneic 51Cr-labe1 led MBL-2 cells in the absence or presence of
lectin (Con A or sCon A, 6 jigml). Various drugs at the
indicated concentrations were also added and the mixtures were
incubated for 10 hrs.
As shown in Fig. 3.14 and 3.15, EGTA and coiMan were very
potent inhibitors of LDCC against MBL-2 target whereas both H7
Figure 3.13 The effect of divalent metal ions on succinyl Con A-
mduced lymphocyte-mediated cytotoxicity. Normal mouse
splenocytes were incubated with Cr-1abe1 led MBL —2 tumour target
cells in the absence (hatched bar) or 'esence (open bar) of
sCon A (6 pgml) at an E:T ratio of 100:1. With the exception of
the control group (C), EGTA was added to the mixtures at a final
concentration of 0.8 mM. Ca (a) and Mg (b) at various
concentrations were then added (except the control group) and the
specific 5lCr-release was determined in a 10 hr assay.























Figure 3.14 The inhibitory effect of various pharmacologic
agents on Con A-induce lymphocyte-mediated cytotoxicity against
syngeneic tumour. Normal C57 BL6J mouse splenocytes were
incubated with 51Cr-label led MBL-2 target cells at an E:T ratio
of 100:1 in the absence (a) or presence (b) of Con A (6 jagml).
Various pharmacologic agents at the indicated concentrations were
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Figure 3.15 The inhibitory effect of various pharmacologic
agents on succinyl Con A-induced lymphocyte-mediated
cytotoxicity against syngeneic tumour. Normal C57 BL6J mouse
splenocytes were incubated with 51Cr-labe1 led MBL-2 cells at an
E:T ratio of 100:1 in the absence (a) or presence (b) of sCon A
(6 pgml). Various pharmacologic agents at the indicated
concentrations were also added and the mixtures were incubated
for 10 hrs.
and W7 showed only a slight, though significant, inhibition of
the lectin-induced cytolysis of this tumour target. In contrast,
NEO seemed to have no inhibitory effect on LDCC against MBL-2
eelIs.
DISCUSSION
A number of earlier reports (Moller, 1965; Rubens and Henney
1977; Thierry et al.,1977; Tartof and Fitch, 1978; Waterfield et
al_., 1981; Eugene et a_l_. 1982) had shown that only alloimmune
lymphocytes or Con A or PHA-activated lymphocytes could kill
syngeneic and allogeneic tumour cells in the presence of lectins.
Significant cytolysis, however, was not detected when normal
splenocytes were used as the effector cells. In contrast, the
present investigation has demonstrated that mitogenic lectins
such as PHA, Con A and succinyl Con A are guite capable of
inducing normal mouse splenocytes to lyse a variety of syngeneic
and allogeneic tumour targets. These results are in line with a
recent report which showed that freshly isolated human peripheral
blood mononuclear cells (PBMC) were capable of mediating strong
cytotoxicity against adherent HEp-2 cells in the presence of Con
A (Perl et al., 1984). Although the reason for the apparent
discrepancy of the present findings with that of others is
unclear. This may be attributed to the fact that most of the
earlier investigators had used a very short incubation time
(usually 4 hrs or less) andor a very high dose of Con A
(usually 20 pgml) for their assays. In contrast, the present
results showed that the optimal concentration of Con A for the
induction of normal splenocyte cytotoxicity was about 3-6 pgml.
In addition, maximum lysis occurred at 6—12 hrs after incubation
of effector and target cells, depending on the type of target
cells being used. Moreover, the tumour targets commonly used by
others were mainly EL-4 and P815 cells, which were found to be
relatively poor targets in my experimental svsten
In order to study the induction of normal splenocyte
cytotoxicity by lectins, normal splenocytes were incubated with
r-labelled tumour target cells in the presence of various
concentrations of lectins. It was found that both native lectins
(Con A and PHA) and lectin derivative such as succinyl Con A
(sCon A) could induce significant normal splenocyte cytotoxicity
against tumour targets in a dose-dependent manner. It can be
seen that both Con A and sCon A were much more potent than PHA
for the induction of LDCC. Moreover, different tumour targets
showed different susceptibility to lectin-induced cytolysis. The
present results indicated that the syngeneic, NK-insensitive MBL-
2 cells and the allogeneic, NK-sensitive YAC-1 cells were
efficiently killed by normal C57 BL6J mouse splenocytes in the
presence of lectins when compared to that of the WEHI-3 and P815
cells which were of intermediate sensitivity to lysis. EL-4
cells, on the other hand, were found to be a poor target for LDCC
since very low levels of cytotoxicity were induced by the
lectins. The difference in susceptibility of these tumour
targets may well be explained by the fact that different tumour
cells have different surface components such as glycoproteins and
glycolipids so their interactions with lectins may be guite
different.
I have compared the induction of LDCC by Con A to its
succinylated derivative. Unlike that of Con A, the sCon A-induced
cytotoxicity against MBL-2 and YAC-1 tumour targets was not
diminished at higher concentrations of the lectin. Similarly,
Hadden et al. (1976) had shown that sCon A did not exhibit
diminished mitogenic action at higher concentrations as compared
uO that of Con A. Although Con A and sCon A are both mitogenic
for murine and human lymphocytes (Gunther et ad., 1973, Hadden et
al•' 1976), it has been reported that sCon A differs from native
Con A in that it is 10 fold less agglutinating for lymphocytes,
it does not induce patch and cap formation and does not inhibit
anti-Ig induced capping (Edelman, 1974). Why the dose-response
curves of LDCC induced by Con A and sCon A are different is not
entirely clear. Perhaps this may be caused by the conversion of
Con A from the tetrameric to the dimeric form as a result of
succinylation (Gunther et al., 1973). It is conceivable that the
reduced induction of LDCC by Con A at higher concentrations may
be due to the extensive crosslinking of cell surface receptors
since Con A is tetrameric at pH above 5.6. Succinyl Con A, on
the other hand, remains dimeric at pH above 5.6 and as a result
of the reduced valence of sCon A, extensive crosslinking of
receptors may not occur at higher lectin concentrations and thus
a diminished induction of LDCC was not observed. Alternatively,
the difference observed with sCon A and Con A may also be due to
the alteration in the charge of Con A induced by succinylation.
Moreover, unlike Con A, it was found that sCon A did not increase
the level of cyclic AMP at higher concentrations (Hadden et al.,
1976). Since cyclic AMP is an important second messenger in many
pathways of cellular activation, increasing concentrations of
cyclic AMP may also influence the induction of LDCC by Con A.
This possibility is supported by a recent report which showec
that pretreatment of CTL with cholera toxin or other agents that
raised the intracellular level of cAMP in CTL had resulted in£
partial inhibition of the T cell receptor (TcR)-triggered lethal
hit delivery to the target cell, and almost completely blocked
the TcR-triggered exocytosis of granules from CTL (Takayama et
a 1., 1988). However, whether the reduced ability of Con A at
higher concentrations to induce LDCC is due to the increased
level of intracellular cAMP in this system remains to be
determined.
In order to characterize the nature of effector cells
mediating LDCC, mouse splenocytes were either stimulated in. vivc
with poly I:C or inactivated in vitro with mitomycin C. It was
found that both poly I :C-stimulated splenocytes and MiMC-treated
splenocytes were equally effective in mediating cytotoxicity
against tumours in the presence of lectins when compared to that
of the normal, untreated splenocytes. These results indicate
that neither prior activation of effector cells in vivo nor
proliferation of effector cells in vitro is a prerequisite for
induction of LDCC. On the other hand, whether de novo RNA and
protein synthesis may play a role on the induction of LDCC has
yet to be determined.
To determine the cell type(s) that is responsible for
mediating LDCC, normal mouse splenocytes were either depleted of
rp 30is by treatment with anti~Thy 1-2 antibody and complement or
enriched for T cells by passage through nylon wool column. The
data clearly showed that the lectin-induced cytolysis of tumour
targets was completely abrogated by anti-Thy 1.2 antibody anc
complement treatment whereas enrichment of T cells had resultec
in increased levels of lectin-induced cytotoxicity against
tumours. These results, when taken togehter, strongly suggest
that the lectin-induced cytotoxicity is mediated by T cells.
Such a finding is consistent with many others who showed that the
major effector cells in LDCC are T lymphocytes (Bevan and Cohn,
1975; Rubens and Henney, 1977; Schuber and Lucas, 1981; Bonavida
et al., 1983; Perl et al., 1986). However, it has been reported
that monocytes and polymorphonuclear cells can also mediate LDCC
and that the choice of lectins and targets is of primary
importance in connection with which effector cells are involved
in a given LDCC system (Jondal and Targan, 1978; Yue et al., 1981;
Yamazaki et a1., 19 8 3).
.It is unclear how lectins can induce normal splenocytes to
kill a syngeneic or allgeneic tumour. Some investigators
suggested that the lectin served merely as a bridge, bringing an
inherently lytic T cell into close approximation with the target
cell (Forman and Holier, 1973; Bevan and Cohn, 1975). Other
studies, however, demonstrated that some agglutinating agents,
while bringing the effector and target cells in close contact,
were not able to mediate LDCC (Bonavida and Bradley, 1976; Green
et al., 1978). Therefore, it is of great interest to examine
whether lectin pretreatment of the effector andor target cells
would support cytolysis. The present results clearly showed that
pretreatment of either effector or target cells with succinyl
Con A failed to induce significant LDCC against the two tumour
targets. This would seem to indicate that the mere 'activation
or modification' of either effector or target cells alone by
sCon A is insufficient to induce cytolysis and that the
continuous presence of sCon A or the bridging of the effector to
the target is essential for cytolysis to occur. On the contrary,
pretreatment of either effector or target cells with Con A could
induce significant LDCC against the two tumour targets. There
are at least two likely explanations for this observation.
Firstly, Con A activation or modification of either the
effector or target cells alone is sufficient to mediate LDCC.
Alternatively, since Con A is polyvalent, it could still interact
with both effector and target cells such that bridging would have
occurred even if both pretreatment and washing were performed.
Of course the possibility exists that Con A may serve a dual role
in this process: activation of effector or target and bridging
the effector to its target. Clearly, more experiments are
required in order to distinguish these possibilities.
As initial attempts to elucidate the mechanism of lectin-
induced lymphocyte—mediated cytotoxicity against tumours in tne
present system, I have studied the temperature-dependence and
calcium ions requirement in the cytolysis induced by the lectins.
Moreover, the effect of various pharmacologic agents on the
induction of LDCC was also examined. It has been well documented
that the antigen-specific T cell-mediated cytotoxicity is a
temperature-dependent process (Berke, 1980). Similarly, the
present data showed that the lectin-induced cytolysis on!
occurred at 37 C while cooling the incubation mixture to 4°C c
by maintaining the effector and target cells at room temperatui
failed to induce any significant lysis. It is conceivable the
temperature may affect LDCC in at least three ways: 1. tl
activation of the cellular response that may be reguired fc
killing to occur; 2. the binding of lectins to the surface of tl
effector and target cells; and 3. the target cell disintegratic
(release of 5lCr) process.
It has been well established that Ca play an important role
in many cellular activation processes. The addition of the
calcium-chelating agent EGTA to the assay system is known to
inhibit the antigen-specific cytotoxicity (Plaut et a_l., 1976).
In this investigation, it was found that EGTA at 0.8 mM
concentration could inhibit nearly all the lectin-induced
cytotoxicity against tumours, indicating that Ca may play a
crucial role in this process. This is further supported by the
+ + + + .
fact that the addition of Ca but not Mg was effective m
reversing the inhibitory effect of EGTA on LDCC. This raised the
question as what role(s) Ca++ play in LDCC against tumours.
4 4
Obviously, there are several possibilities. Firstly, Ca may
4 4,,
affect cell-cell interaction. Secondly, Ca may be involved m
4 4
lectin binding to effector and target cells. Thirdly, Ca may
be involved in intracellular signalling since there is an
increased calcium influx into the effector cells during the early
events of mitogen triggering (Whitney et al., 1972). Fourthly,
Ca may be directly involved in the early stages of Ca++-
dependent lytic processes. Therefore the exact role(s) that
Ca play in LDCC has yet to be established.
Thus it can be seen that the cytolysis induced by lectins has
requirements for temperature and calcium ions similar to that of
the antigen-specific T ce11-mediated lysis. As temperature and
Ca++ have been shown to influence the reorientation of the
perinuclear Golgi apparatus and the microtubule-organizing center
(Kupfer et ad., 1985), perhaps this reorientation process may
also be important in the lectin-induced cytolysis of tumours.
To determine whether the binding of the lectins (Con A,
sCon A) to the effector or target cell surface is a prerequisite
for triggering cytolysis, a-methy1-D-mannoside, an effective
inhibitor of Con A, was used in the present study. It is known
that amMan can rapidly bind to Con A and remove it from the cell
surface (Powell and Leon, 1970). It was found that only a high
concentration of amMan (12.5 mgml) was effective in inhibiting
the LDCC induced by Con A whereas a much lower concentration
(0.63 mgml) of amMan was sufficient to inhibit all LDCC induced
by sCon A. These results would seem to suggest that the binding
affinity of sCon A for effector and target cells was much weaker
than that of Con A and hence amMan could bind to sCon A and
readily displaced it from the cell surface much more efficiently
as compared to that of Con A.
In order to have a better insight into the mechanism of
LDCC, several pharmacologic agents were used to inhibit or
interfere with the essential processes that are involved in the
intracellular signalling events during cell activation. H7 is an
inhibitor of protein kinase C which is a main enzyme involved in
cell activation whereas the W7 is a calmodulin antagonist. These
two drugs at their optimal concentrations (100 uM and 10 uM
respectively) could significantly inhibit normal splenocyte
proliferation whereas the same concentrations of drugs only
slightly inhibited the LDCC induced by the two lectins.
Similarly, neomycin is an inositol phosphate (IP) turnover
inhibitor which could also inhibit cell proliferation when
present at a concentration of 10 mM. However, the same
concentration of this drug seemed to exert no inhibitory effect
on LDCC against the MBL-2 tumour. A likely explanation for these
findings is that the induction of LDCC by lectins may involve
several pathways so inhibition of one pathway may not affect
greatly the results. This possibility is currently being
investigated in our laboratory.
In conclusion, mitogenic lectins such as Con A and succinyl
Con A can induce significant splenocyte cytotoxicity against
various syngeneic r.nd allogeneic tumours. The lectin-induced
effector cells are T cells. Cytolysis is both calcium ions and
temperature-dependent. The question remains open as to what the
lectin is providing in the cytotoxic assay. However, cytolysis
is abolished by the addition of a-methy1-D-mannoside to the assay
system indicating that the binding of the lectins to the effector
andor target cell surface may be critical for lysis to occur.
CHAPTER FOUR: INDUCTION OF NONSPECIFIC LYMPHOCYTE-MEDIATED
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It has been well documented that ce11-mediated cytotoxicity
depends on transduction signals to transform the initial
effector-target cell contact into a fully lytic event (Berke,
1983). For antigen-specific cytotoxic T lymphocytes (CTL), this
depends on the capacity of the T cell receptor for antigen (TcR)
on the effector cell surface to recognize and bind to the
relevant antigen on the target cell surface so as to transmit
this recognitive event to the interior of the CTL and then
activate it (Isakov et ad.,1987). Other structures such as Lyt-2
or L3T4 molecular complexes and LFA-1 molecule may also
contribute to the overall avidity of interaction between effector
and target cells in the murine system but the mechanism by which
this occurs is not clear( Davignon et ad., 1981; MacDonald et
ad., 1982). Recent studies suggest that a signal transduction
pathway involving inositol phospholipid hydrolysis is important
in T cell activation and function. In this pathway, receptor
occupation by a ligand stimulates a phospholipase C to hydrolyze
membrane bound phosphatidy1inositol 4,5—bisphosphate into two
products: the diacylglycerol(DG) and inositol 1,4,5—
trisphosphate(IP3). DG activates protein kinase C (PKC) by
increasing its affinity for Ca while IP3 mobilizes Ca from the
endoplasmic reticulum, thereby increasing the free intracellular
Ca concentration. The activation of PKC and elevation of
cytoplasmic free Ca++ may both play important roles in the early
events of signal transduction in T lymphocytes( Berridge and
Irvine, 1984; Nishizuka, 1986).
Pharmacological agents such as phorbol esters and calcium
ionophores are particularly useful for studying the molecular
events of T cell activation as they apparently act directly on
intracellular targets rather than through antigen-specific
receptors on the T cell surface. Phorbol esters such as PMA and
TPA have been demonstrated to provide an antigen-like activation
signal to T cells and this is presumably mediated through PKC
activation (Nishizuka, 1984; 1986). On the other hand, calcium
ionophores such as A23187 and ionomycin have been used to induce
artificial increases in cytoplasmic Ca++ levels in T lymphocytes
(Maino et al., 1974; Mastro and Smith, 1983).
It has been reported that with murine CTL clones, calcium
ionophore and phorbol ester can substitute for antigen in the
induction of killer cells from primed precursors (Albert et al.,
1985; Isakov and Altman, 1985). Lancki et al. (1987), on the
other hand, have shown that cloned murine CTL can also be
triggered by phorbol ester together with a calcium ionophore to
lyse syngeneic or third party target cells efficiently.
Interestingly enough, Ju et a_l. (1987) demonstrated that PMA and
A23187 syngergistically activated murine L3T4 clones to express
potent nonspecific cytolytic activity. Moreover, Mikael et al.
(1987) have shown that TPA plus A23187 can directly induce human
lymphocytes to kill certain tumour targets nonselectively. In
view of these observations, it is of particular interest to
examine whether normal mouse lymphocytes can be similarly
triggered by PMA andor A23187 to lyse various syngeneic and
allogeneic tumour cell lines. In the present study, it was found
that PMA but not A23187 alone was able to trigger normal
splenocytes to mediate cytolysis against various tumour targets.
In addition, the PMA-induced cytotoxicity was found to be
significantly enhanced with the simultaneous presence of A23187.
RESULTS
4 -1 Dose response of drug-induced lymphocyte-media tec
cytotoxicity against tumours
In order to determine whether phorbol ester (PMA) ando
calcium ionophore (A23187) can induce normal mouse splenocyte t
lyse tumour targets nonspecifically in vitro, norma
splenocytes from C57 BL6J mice (H-2b) were preincubated wit:
different concentrations of two drugs either alone or in variou:
combinations for 1 hr at 37°C. The 51Cr-labe1 led allogeneic YAC-
3 b
cells (H-2) or syngeneic MBL-2 cells (H-2) were then adde
and the mixtures were further incubated at 37 °C for 6 hrs and li
hrs respectively. The specific lysis of the these two tumou:
targets was then determined.
Data from Figure 4.1 showed that PMA at a concentration of
6.3 ngml significantly enhanced the natural splenocyte-mediated
cytotoxicity against YAC-1 target. Such an enhancement of
splenocyte killing on YAC-1 cells, however, was less marked at
higher concentrations of PMA. In contrast, at lower
concentrations (e.g. 1.6 ngml) of PMA, a slight suppression of
the endogenous natural killing on YAC-1 target was observed. On
the other hand, PMA alone at high concentrations (25-100ngml)
induced significant, albeit low, splenocyte killing on MBL-2
target whereas at lower concentrations, direct induction of
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Figure 4.1 Dose response of PMA-induced Iymphocyte-mediated
cytotoxicity on YAC-1 and MBL-2 targets. Normal mouse
splenocytes were preincubated with various concentrations of PMA
for 1 hr at 3 7 °C before the addition of 61Cr-1 abe 1 led Yac-1 (a)
and MBL-2 (b) tumour target cells. Cytolysis was determined in a
6 hr (a) or 10 hr (b) 51Cr release assay and the effector-to-
target cell ratio was 100:1.
seen.
The influence of calcium ionophore A23187 on the
cytotoxicity of normal splenocytes towards the two tumour targets
was investigated. Unlike PMA, it was found that A23187 at
nontoxic concentrations (up to 2.5 pM) did not induce any
detectable splenocyte killing on the MBL-2 tumour target (Fig.
4.2). In contrast, it exhibited an inhibitory effect on the
endogenous natural killer activity of the splenocytes on YAC-1
cells at higher concentrations (1.25-2.5 pM).
Results in Figure 4.3 clearly indicated that the
combinations of PMA and A23187 at various concentrations in most
cases induced higher splenocyte cytotoxicity against the two
tumours targets when compared to that induced by the same
concentration of PMA alone. For YAC-1 target, a combination of
6.3 ngml PMA and 0.63 pM A23187 induced the highest level of
splenocyte cytotoxicity whereas a combination of 25 ngml PMA
and 2.5 pM A23187 was optimal for MBL-2 target. Therefore, these
optimal combinations of PMA and A23187 were chosen for further
studies. Since PMA alone at a concentration of 6.3 ngml could
also induce significant lymphocyte-mediated cytotoxicity against
the YAC-1 target so this was also included for subsequent
investigations.
It should be noted that in the absence of effector cells,
treatment of the two tumour targets with PMA andor A23187 at all
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Figure 4.2 Dose response of A23187-induced lymphocyte-mediated
cytotoxicity on Y A C— 1 and MB L— 2 targets. Normal mouse
splenocytes were preincubated with various concentrations of
A23187 for 1 hr at 37°C before the addition of Cr-labelled YAC-1
(a) and MBL-2 (b) tumour target cells. Cytolysis was determined
in a 6 hr (a) or 10 hr (b) 51Cr release assay and the effector-
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Figure 4.3 The effect of combinations of various concentrations
of PMA and A23187 on the induction of lymphocyte-mediated
cytotoxicity on YAC-1 and MBL-2 targets. Normal mouse
splenocytes were preincubated with various concentrations of PMA
( lOOngml; A-A 25ngml; A-A 6.3ngml; O-O 1.6ngml;
medium) and A23187 for 1 hr at 37°C before the addition of
5tr-labelled YAC-1 (a) and MBL-2 (b) tumour target cells.
Cytolysis was determined in a 6 hr (a) or 10 hr (b) Cr release
assay and the effector-to-target cell ratio was 100:1.
spontaneous release of 51Cr from the target cells, indicating that
these two drugs, when present alone or in combinations, are not
toxic to the two tumour targets under the prescribed experimental
conditions.
4.2. Time course of PMA andor A23187 -induced lymphocyte-
mediated cytotoxicity against tumours
To determine the time course for the induction of
splenocyte cytotoxicity against the two targets (YAC-1 and MBL-2
cells) by PMA andor A23187, normal mouse splenocytes were
preincubated with PMA andor A23187 for 1 hr at 37°C and then
51
incubated with Cr-labelled YAC-1 and MBL-2 cells for various
time periods (2-12 hrs). As shown in Figure 4.4, it can be seen
that the PMA andor A23187 induced cytolysis increased with time
with both tumour targets. With YAC-1 target, the greatest
difference in the percentage lysis between the control and PMA-
treated groups reached a plateau at about 6 hrs whereas the
percentage cytolysis induced by PMA+A23187 was maximal at about
10 hrs. However, with MBL-2 target, cytolysis induced by
PMA+A23187 increased progressively with time and a plateau was
not seen up to 12 hrs of incubation (Fig. 4.4). Since in many
pq0271ng experiments it was found that an incubation period
exceeding 10 hrs was often associated with high spontaneous
lysis, therefore, a 6 hr 51Cr-release assay was chosen for YAC-1



































- a c o -i r a
iKiriiPATinKi TIMP fuminc;
Figure 4.4 Time course of PMA andor A23187-induced lymphocyte-
mediated cytotoxicity against tumours. Normal mouse splenocytes
were preincubated with PMA (6.3ngml)( O O); PMA
(6.3ngml)+ A23187 (0. 63 pM)( A-A) or medium() for
1 hr at 37 °C and then incubated with 51Cr-labe 1 led YAC-1 target
(a). Similarly, normal mouse splenocytes were preincubated with
PMA (25 ngml)+ A23187 (2. 5 pM)( O-O) or medium(•-•) for
1 hr at 37 °C and then incubated with 51Cr-label led MBL-2 target
(b). The effector-to-target ratio was 100:1. The percentage
lysis was determined every 2 hrs for 12 hrs. The differences
between the percentage lysis of tumour target in the absence and
presence of PMA(—) or PMA+ A23187() are
referred as the PMA- or PMA+A23187- induced cytolysis.
4•3 The induction of lymphocyte-mediated cytotoxicity against
various tumours by PMA andor A23187
From the previous experiments, it was found that PMA andor
A23187 could induce splenocyte cytotoxicity against the YAC-1 and
MBL-2 tumour targets. It is of interest to know whether PMA
andor A23187 can also induce normal splenocytes to mediate
cytotoxicity against other tumour targets. Results in Table 4.1
showed that PMA alone was able to trigger a low level of
lymphocyte-mediated splenocyte cytotoxicity against various
tumour targets including P815, EL-4 and WEHI-3 cells at a
concentration of 25 ngml. In contrast, A23187 at a concentration
of 2.5 pM did not induce any detectable cytolysis against these
tumours. However, in the presence of PMA (25 ngml) and
A23187 (2.5 pM), a significantly higher level of lymphocyte-
mediated cytotoxicity against these tumour targets was observed
as compared to the cytolysis induced by PMA alone. Moreover, it
was found that different tumour target cells showed different
susceptibility to PMA andor A23187 induced-cytolysis.
4.4 Determination of the cell type which is responsible for PMA
andor A23187 induced-lymphocyte-mediated cytotoxicity against
tumours
In order to characterize the nature of effector cell
population (s) which is responsible for mediating PMA andor
A23187-induced splenocyte cytotoxicity against tumours, T cells
were depleted from normal mouse splenocytes by treatment with
Table 4.1 PMA andor A23187- induced lymphocyte-mediated
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Normal mouse splenocytes were preincubated with PMA (25 ngml)
andor A23187 (2.5 pM) at 37°C for 1 hr. Then 5Cr-labelled
tumour target cells were added and cytolysis was determined in a
10 hr 51Cr release assay.
□ Effector-to-target cell ratio.
monoclonal anti-rhy 1.2 antibody and complement as described in
Materials and Methods. The untreated or complement-treated groups
served as the positive controls. Then these three groups of
effector cells were preincubated with PMA andor A23187 for 1 hr
at 37 °C and then tested for splenocyte cytotoxicity against
YAC-1 and MBL-2 cells. Data from Table 4.2 showed that 1.
complement alone did not affect the PMA andor A23187-induced
lymphocyte-mediated cytotoxicity on both tumour targets; 2.
the PMA- induced splenocyte cytotoxicity against both tumour
targets diminished significantly by treatment with anti-Thy 1.2
antibody and complement; 3. the PMA+A23187-induced splenocyte
cytotoxicity against YAC-1 cells was completely abrogated whereas
the PMA+A23187 -induced cytolysis of the MBL-2 cells was
significantly decreased by anti-Thy 1.2 antibody and complement
treatment. These results, when taken together, indicate that
the PMA andor A23187- induced cytolysis is largely T-cell
mediated.
4.5 Effect of T-cell enrichment by nylon wool column on PMA
andor A23187-induced lymphocyte-mediated cytotoxicity
To further establish the nature of effector cells involved
in PMA andor A23187-induced lymphocyte-mediated cytotoxicity,
normal mouse splenocytes can be enriched for T cells by
fractionation on nylon wool column as described in Materials and
Methods. Both the unfractionated and the fractionated cells were
preincubated with PMA andor A23187 for 1 hr at 37 C. The Cr
Table 4.2 Determination of the cell type which is responsible
for PMA andor A23187-induced 1ymphocvte-mediated cytotoxicity
Tumour
target Grout
51% .Snpni fin fr rpl paRf






















5. 6+ 0. 7
5.6+0.2







Normal splenocytes were either untreated (UNT) or treated with
complement alone(C1) or with anti-Thy 1.2 antibody and
complement (Ab+C1) as described in Materials and Methods.
For YAC-1 target, these three groups of splenocytesQ were
preincubated with 6.3 ngml PMA andor 0.63 pM A23187 at 37 C for
1 hr and then incubated with Cr-labelled YAC-1 target cells for
6 hrs. For MBL-2 target, these three groups of splenocytes were
preincubated with 25 ngml PMA andor 2.5 pM A23187 at 37 C for 1
hr and then incubated with 51Cr-label led MBL-2 target cells for 10
hrs. The effector-to-target cell ratio was 100:1.
labelled YAC-1 and MBL-2 target cells were then added and the
mixtures were further incubated for 6 hrs and 10 hrs
respectively. It can be seen that the T ce11-enriched, nylon
wool nonadherent cells could be induced by PMA andor A23187 to
mediate significantly higher cytotoxicity against both tumour
targets as compared to that of the unfractionated spleen cells
(Table 4.3). In contrast, the nylon wool adherent cells, which
contained mainly B cells and macrophages, were found to be much
less effective in mediating cytolysis against the two tumour
targets when stimulated by PMA andor A23187. These results
strongly indicate that the main effector cells responsible for
the PMA andor A23187-induced cytolysis are T cells.
4.6 Effect of pretreatment of splenocytes with PMA andor
A23187 on the induction of lymphocyte-mediated cytotoxicity
against tumours
Previous experiments have shown that PMA and or A23187
can induce normal mouse splenocyte cytotoxicity to lyse a
variety of tumour targets. However, it should be noted that the
two drugs were present continuously throughout the assay. It is
of interest to determine whether a short preincubation of
sp]_0nocytes with the two drugs f ol lowed by extensive washings
can similarly trigger cytolysis. Therefore, normal splenocytes
preincubated with PMA andor A23187 for 1 hr and then washed
with plain rpm I medium for 3 times to minimize residual
extracellular drugs. These PMA andor A23187 pretreated
splenocytes were then incubated with Cr— labelled Y AC~ 1 cells
Table 4.3 Effect of T cell enrichment by nylon wool column on




































Normal splenocytes were fractionated on nylon wool column into
two fractions: the nonadherent fraction (NAF) and adherent
fraction (ADF). The unfractioned cells (UNF) were included as a
control.
For YAC-1 target, these three groups of cells were preincubated
with 6.3 ngml PMA andor 0.63 pM A23187 at 37°C for 1 hr and
then incubated with Cr —labe1led YAC—1 cells for 6 hrs. For MBL-
2 target, these three groups of cells were preincubated with 25
ngml PMA andor 2.5 pM A23187 at 37 °C for 1 hr and then
incubated with 51Cr-labelled MBL-2 cells for 10 hrs. The
effector-to-target cell ratio was 50:1.
and MBL-2 cells for 6 hrs and 10 hrs respectively. Data from
Table 4.4 showed that a short pulse of normal splenocytes with
PMA andor A23187 was sufficient to trigger significant
splenocyte cytotoxicity against the two tumour targets and the
levels of cytolysis were similar to those induced by the
continuous presence of PMA andor A23187 throughout the assay.
4.7 The effect of temperature on the induction of lymphocyte-
mediated cytotoxicity against tumours by PMA andor A23187
In order to study the temperature requirement for induction
of efficient lysis of the targets by PMA andor A23187, normal
splenocytes were preincubated with PMA andor A23187 for 1 hr at
37 °C. The 51Cr-label led YAC-1 cells were then added and the
mixtures were further incubated at 37°C, room temperature (22 °C)
or 4 °C for 6 hrs. Results in Table 4.5 showed that by cooling
the cell mixture to 4°C or by maintaining the effector and
target cells at room temperature through the whole incubation
period, the induction of lymphocyte-mediated cytotoxicity against
the YAC-1 tumour target by PMA andor A23187 was completely
inhibited.
Table 4.4 Effect of pretreatment of splenocytes with PMA andor




























Normal splenocytes were pretreated with 6.3 ngml PMA andor
0.63 uM A23187 at 37°C for 1 hr and then washed 3 times with
plain RPMI medium. The PMA andor A23187 pretreated splenocytes
were then incubated with 51Cr-labe1 led YAC-1 tumour cells for 6
hrs.
Normal splenocytes were pretreated with 25 ngml PMA andor
2.5 uM A23187 at 37°C for 1 hr and then washed 3 times with
plain RPMI medium. The PMA andor A23187 pretreated splenocytes
were then incubated vith 51Cr-label led MBL-2 tumour cells for 10
hrs.
□ Effector-to-target cell ratio.
Table 4.5 The effect of temperature on the induction of














50:1 15.1+1.2 28.6+0.4 41.9+1.1
100:1 23.7+0.5 37.9+0.4 54.7+0.9
50:1 1.1+0.6 5.7+0.6 1.4+0.8
100:1 2.2+0.5 9.7+0.2 3.4+0.7
50:1 1.3+0.5 0 0.2+1.3
100:1 0.9+0.9 0.8+1.0 0.3+0.7
Normal splenocytes were preincubated with 0.63 ngml PMA andor
0.63 pM A23187 at 37°C for 1 hr. The 51Cr-labelled YAC-1 target
cells were then added and the mixtures were incubated at the
indicated temperature in an air —tight box containing 5-s CO2 in
air. Cytolysis was then determined in a 6 hr s1Cr release assay.
□ Effector-to-target cell ratio.
DISCUSSIC
Recent studies have shown that phorbol ester, a potent
activator of protein kinase C, when present alone or in
combination with calcium ionophore, can mimic antigenic
stimulation and is effective in triggering T cell activation
(Isakov et ad., 1986; Weiss and Imboden, 1987). In this chapter,
the effect of PMA (a phorbol ester) and A23187 (a calcium
ionophore) on triggering of normal mouse splenocytes to mediate
cytotoxicity against various tumour targets was examined. It was
found that PMA alone was able to trigger normal splenocytes to
display a significant, albeit low, level of cytotoxicity against
tumours. This nonspecific cytotoxicity was dependent on the
concentration of PMA and could be observed with various tumour
targets. Interestingly enough, others have found that treatment
of murine or human cytotoxic T effector cells with phorbol ester
alone can lead to either inhibition or enhancement or lytic
activity, depending on which effector-target system is used, the
duration of phorbol ester action and the concentration of drug
that is used (Orosz et al., 1983; Bensussan et al., 1985;
Russell, 1986; Schrezenmeier et aI., 1986). On the other hand,
it was found that calcium ionophore A23187 alone could not induce
any detectable cytotoxicity against the tumour targets that had
been tested. In contrast, it rather inhibited the endogenous NK
activity of the splenocytes against YAC-1 cells at high
concentrations. This finding is in line with a recent report
(Mikael et al., 1987) which showed that a short term pretreatment
of human lymphocytes with A23187 alone suppressed normal human NK
activity. The combination of the PMA and A23187, however, was
found to induce much higher splenocyte killing against a variety
of tumour targets, including the syngeneic (MBL-2, EL-4) and
allogeneic (YAC-1, WEHI-3 and P815) tumour cell lines. Moreover,
it should be noted that optimal induction of normal splenocyte
cytotoxicity against two different tumour targets (i.e. MBL-2 and
YAC-1 cells) required different combinations of the two drugs.
The reason for such an observation is, however, unclear.
Nevertheless, these results are quite similar to a number of
recent reports which showed that these two drugs act
synergistically to induce normal human lymphocytes and cloned
murine cells to lyse a variety of tumour targets (Ju et a1.,
1987; Lancki et ad., 1987; Mikael et ad., 1987). Moreover, the
present observations are consistent with other reports which
showed that phorbol ester and calcium ionophore can cooperate
synergistically to initiate different parameters of T cell
activation such as expression of proliferation-related genes,
cellular proliferation, lymphokine secretion and surface receptor
expression (Albert et ad., 1985; Trunch et a_l., 1985; Ju et ad.,
1987; Kumagai et ad., 1987). Since PMA is an activator of PKC
whereas A23187 can elevate intracellular Ca, such a synergism
between PMA and A23187 strongly suggests that cooperation
between PKC and intracellular Ca++ may be important in signal
transduction during T cell activation and function.
Time course experiments showed that the PMA+A23187-induced
splenocyte cytotoxicity against tumour targets was detectable at
about 4 hrs of incubation and this increased progressively with
time. With YAC-1 target, it peaked at 10 hrs after incubation
whereas with MBL-2 target, maximum cytolysis had not yet been
reached even up to 12 hrs of incubation. The work with murine T
cell clones demonstrated that the triggering of lysis by
PMA+ A23187 occurred much more rapidly, and a very short
incubation period (about 3 hrs) was sufficient for the expression
of maximal cytolytic activity (Ju et al., 1987; Lancki et ad.,
1987). These rapid kinetics indicate that the lytic activity
induced by PMA and calcium ionophore may result primarily from
the triggering of conventional lytic mechanisms rather than
through activation of lymphokine production which requires a much
longer period of incubation. It is known that PMA and A23187 can
be used to activate a variety of cell types including macrophages
and B cells (Bertoglio, 1983; Kiyotaki and Bloom, 1984; Drysdale
et ad., 1987). Therefore, in order to determine the main
effector cell type(s) which is involved in the induction of
splenocyte cytotoxicity by PMA+A23187, normal splenocytes were
depleted of T cells by treatment with monoclonal anti-Thy 1.2
antibody and complement before preincubation with PMA andor
A23187. It can be seen that the PMA+A23187 induced cytolysis of
tumour targets was markedly diminished by anti-Thy 1.2 antibody
and complement treatment. Moreover, by fractionation of normal
splenocytes on nylon wool column, it was found that the
nonadherent cells (consisted of mainly T cells) but not the
adherent cells (consisted of mainly B cells and macrophages)
treated with PMA andor A23187 expressed significant cytolytic
activity. These data, when taken together, strongly suggest
that the PMA+A23187-induced splenocyte cytotoxicity was T cell-
mediated. Similarly, Ju et al. (1987) found that only the L3T4+
inducer T cells but not macrophages or B cells could be activated
by PMA plus A23187 to express cytolytic function.
It is unclear how PMA andor A23187 can induce normal mouse
splenocytes to kill the syngeneic and allogeneic tumour cells.
Therefore, it is of great interest to examine whether a brief
exposure of normal splenocytes to PMA andor A23187 can induce
nonspecific lymphocyte-mediated cytotoxicity against tumours.
The present results clearly showed that a brief exposure (1 hr)
of splenocytes to PMA andor A23187 was sufficient to activate
them to kill the tumour targets nonspecifically. Whether
pretreatment of the target cells alone has any effect on their
subsequent sensitivity to lysis has not yet been investigated.
Nevertheless, other studies have suggested that the action of PMA
andor A23187 is on the effector T cells rather than on the
target cells (Russell, 1986; Schrezenmeier et al., 1986).
In the present study, the temperature requirement in the
cytolysis induced by PMA andor A23187 was also examined. It was
found that PMA andor A23187-activated splenocytes were lytically
active only at 37°C. Cooling the incubation mixture to 4°C or by
maintaining the effector and target cells at room temperature
failed to induce any significant lysis. It is conceivable that
temperature may affect PMA andor A23187 -induced splenocyte
cytotoxicity similar to that of LDCC (see Chapter 3) and CTL in
general (Berke, 1980).
In conclusion, the present study merely demonstrated that
PMA andor A23187 treatment activates a lytic function in normal
mouse splenocytes and the cytolysis observed is T ce11-dependent.
However, the mechanism(s) by which PMA andor A23187 can trigger
the normal mouse splenocytes to lyse tumour targets
nonspecifically has not yet been elucidated. It would be of
great interest to know whether the PMA andor A23187-induced
lysis requires close proximity or physical contact between the
effector and target. In addition, whether the drug-induced lytic
mechanism is identical to the mechanism activated after the
physiological receptor-triggering of CTL awaits further
investigation.
CHAPTER FIVE: GENERATION OF CYTOTOXIC T CELLS AGAINST SYNGENEIC




5.1 Effect of in. vivo immunization with inactivated tumour on
the in. vitro generation of cytotoxic effector cells to
syngeneic tumour
5.2 Cross-reactivity of the cytotoxic cells raised against
MBL-2 cells in vitro




Although it has been well established that the host immune
system has the ability to reject syngeneic tumours,yet tumour-
bearing animals often die from tumour progression despite the
existence of anti-tumour immunity (Hellstrom and Hellstrom,
1969). This may reflect the presence of tumour-induced
immunosuppression or inefficient in vivo sensitization of the
host effector cells( Martin et al., 1973; Fujimoto et a 1.
1976; Levy et al., 1976; Small and Trainin, 1976). In fact, a
number of previous reports showed that syngeneic or allogeneic
cytotoxic cells against tumour targets could be generated by the
in vitro immunization technigue( Berke et aJL_., 1971; Cerottini
et al., 1974; Plata et al., 1975; Glaser and Herberman, 1976;
Kedar et al., 1977; Cheever et al., 1978). Splenocytes from
normal, tumour-immune and tumour-bearing mice can also be used to
generate cytotoxic cells with higher lytic ability. Anti-tumour
activity of lymphoid cells can be generated in vitro that may be
due to by-pass mechanisms that limit effective sensitization in
vivo and tumour-induced immunosuppression( Martin et a1.,1973;
Treves et al., 1975). Moreover, the in. vivo anti-tumour
activity of these cells in vitro generated have also been
reported (Bernstein, 1977; Cheever et a1., 1978; Frenandez—Cruz
et al., 1979).
In our laboratory it was demonstrated previously that
cytotoxic activity against the syngeneic MBL-2 tumour could be
generated by in vitro stimulation of normal C57 BL6J mouse
splenocytes with mitomycin C (MMC)-inactivated MBL-2 cells.
(Wong, 1987). However, the inductive requirements, the antigen
specificity and the nature of these cytotoxic effector cells have
not been elucidated. Therefore, in this chapter, the effect of
in vivo and in. vitro immunizations on the generation of cytotoxic
cells to a syngeneic tumour (MBL-2) was investigated. Moreover,
the antigen specificity and the surface phenotype of these
cytotoxic effector cells were also determined.
results
5•1 Effect of in vivo immunization with inactivated tumour on the
in vitro generation of cytotoxic effector cells to syngeneic
tumour
Previous work in this laboratory have shown that cytotoxic
cells against syngeneic MBL-2 tumour can be generated in vitro by
co-culturing normal C57 BL6J mouse splenocytes with MMC-treated
MBL-2 cells for 6 days (Wong, 1987). It is of interest to
determine whether in vivo immunization with syngeneic inactivated
tumour can enhance the subsequent induction of cytotoxic cells in
vitro.
C57BL6J mice were injected i.v. once (primary immunization)
or twice (secondary immunization) with 107 MMC-inactivated MBL-2
cells. As it was reported that pretreatment of mice with
cyclophosphamide (CY) could increase the ability of tumours to
stimulate specific effector cells involved in anti-tumour
immunity (Glaser, 1979; Hengst et ad., 1981; Ophir et ad., 1984),
therefore, another two groups of mice were included and they were
pretreated with CY (100 mgkg body weight given i.p.) two days
before primary or secondary immunization. In the control groups
mice were similarly injected with the same volume of PBS. The
primary immunized or secondary immunized mice were sacrificed 6
days and 3 days respectively after the last injection of tumour
and the cytotoxic activity in their spleen cells was examined. As
shown in Table 5.1 and 5.2, in vivo immunization alone failed to
Table 5.1 Effect of primary in vivo immunization on the in vitro
generation of cytotoxic cells against a syngeneic tumour
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C57BL6J mice in groups of 4 were injected i.v. either with PBS
(NSC) or with 107mitomycin C (MMC)-inactivated MBL-2 cells (ISC).
A third group of mice were cyclophosphamide pretreated (100 mgkg
given i.p.) 2 days before i.v. injection with 10 MMC-
inactivated MBL—2 cells (CISC Group)• The mice were sacrificed
6 days after tumour immunization and their spleen cells were
tested for cytotoxicity on MBL-2 target in a 8 hr Cr release
assay. In addition, the splenocytes from these 3 groups of mice
were co-cultured with MMC-inactivated MBL-2 cells at a responder-
to—stimu1ator cell ratio of 20:1 in 75 cm tissue culture flasks
for 5 days. After the removal of dead cells and debris by
centrifugation on Ficol1—Isopague gradient, the viable effector
cells were again tested for cytotoxicity in a 8 hr Cr release
assay using labelled MBL—2 cells as target.
□ Effector-to-target cell ratio.
Table 5.2 Effect of secondary in vivo immunization on the ii
vitro generation of cytotoxic cells against a syngeneic tumour
51
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C57 BL6J mice in groups of 4 were injected i.v. on day 0 and
day 21 either with PBS (NSC Group) or with 10 mitomycin C (MMC)-
inactivated MBL—2 cells (ISC Group). A third group of mice were
cyclophosphamide pretreated (100 mgkg given i.p.) on day -2
followed by i.v. injection with 10 MMC-inactivated MBL-2 cells
on both day 0 and day 21 (CISC Group). The mice were sacrificed
3 days after the second tumour immunization and their spleen
cells were tested for cytotoxicity on MBL-2 targets in a 8 hr
sTCr -release assay. In addition, the splenocytes from these 3
groups of mice were co-cultured with MMC-inactivated MBL-2 cells
at a responder-to-stimulator cell ratio of 20:1 in 75 cm2 tissue
culture flasks for 5 days. After the removal of dead cells and
debris by centrifugation on Ficol1-Isopaque gradient, the viable
effector cells were again tested for cytotoxicity in a 8 hr Cr-
release assay using labelled MBL-2 cells as target.
□ Effector-to-target cell ratio.
elicit significant cytotoxic activity against MBL-2 cells, i.e.,
specific cytotoxic activity was always less than 10% even at ar
effector:target cell ratio of up to 50:1. However, when the
immune spleen cells were co-cultured with MMC-inactivated MBL-2
cells for 5 days, a strong cytotoxic response was observed. It
was found that similar levels of cytotoxicity were generated when
the spleen cells were derived from primary or secondary immunized
mice (Table 5.1 and 5.2). In contrast, much lower levels of
cytotoxicity were generated in vitro when the spleen cells were
derived from the unimmunized mice. Moreover, CY pretreatment
slightly enhanced the cytotoxic response generated in vitro and
so unless otherwise stated, mice were usually CY-pretreated in
subsequent experiments.
5.2 Cross-reactivity of the cytotoxic cells raised against MBL-2
cells in vitro
In order to determine whether in vitro induction of
cytotoxic response to a syngeneic tumour is dependent on the
presence of the same tumour in the culture system, the normal or
immune spleen cells from CY-pretreated mice (responders) were
incubated for 5 days in the absence or presence of MMC-treated
MBL-2 cells (stimulators) at a responder:stimulator ratio of
20:1. The results in Table 5.3 and 5.4 clearly showed that 1.
very little cytotoxic activity against the MBL-2 target was
generated in vitro by culturing normal spleen cells alone whereas
a slightly higher level of cytotoxicity was detected when the
normal spleen cells were stimulated with MMC-treated MBL-2 cells
Table 5.3 Cross-reactivity of the cytotoxic cells generated ir
vitro from primary immunized spleen cells
In vitro cell culture'
51









































C57BL6J mice in groups of 4 were cyclophosphamide pretreated
(lOOmgkg given i.p.) on day -2 and then followed by i.v.
injection with either PBS (CSC) or with 107 MMC-inactivated MBL-2
cells (CISC) on day 0. The mice were sacrificed on day 6 and
their spleen cells were co-cultured in the absence or presence of
MMC-inactivated MBL-2 cells at a responder-to-stimulator cell
ratio of 20:1 in 75 cm2 tissue culture flasks for 5 days. After
the removal of dead cells and debris by centrifugation on Ficol±
Isopague gradient, the viable effector cells were tested for
cytotoxicity in a 8 hr 51Cr release assay using labelled MBL-2,
EL-4 and P815 cells as targets.
□ Effector-to-target cell ratio.
Table 5.4 Cross-reactivity of the cytotoxic cells generated i
vitro from secondary immuni7pd snlppn ppi1c
In vitro cell cultur
51








































c t r c
C57 BL6J mice in groups of 4 were cyclophosphamide pretreated
(100 mgkg given i.p.) on day -2 followed by i.v. injection with
either PBS (CSC) or with 107 MMC-inactivated MBL-2 cells (CISC)
on both day 0 and day 21. The mice were sacrificed 3 days after
the second tumour immunization and their spleen cells were co-
cultured in the absence or presence of MMC-inactivated MBL-22
cells at a responder-to-stimulator cell ratio of 20:1 in 75 cm
tissue culture flasks for 5 days. After the removal of dead
cells and debris by centrifugation on Ficol1-Isopaque gradient,
the viable effector cells were again tested for cytotoxicity in a
8 hr 51Cr release assay using labelled MBL-2, EL-4 and P815 cells
as targets.
□ Effector-to-target cell ratio.
in vitro; and 2. the in vivo MBL-2 primed immune spleen cells
cultured without MMC-treated MBL-2 cells could spontaneously
generate a significant level of cytotoxic activity against the
MBL-2 target. However, a much higher level of cytotoxicity was
attained in the presence of MMC-treated MBL-2 cells in vitro.
The antigen specificity of these cytotoxic effector cells
generated in vitro was also tested using other tumour targets
such as EL-4 and P815 cells. As shown in Table 5.3 and 5.4, both
the EL-4 and P815 tumours were significantly lysed by the
cytotoxic cells raised against the MBL-2 tumour, indicating that
such cytotoxic cells did exhibit cross-reactivity with other
tumour targets. Nevertheless, these effector cells showed
significantly higher levels of cytotoxicity towards the MBL-2
tumour that was used for in vivo and in vitro immunizations.
The cross-reactivity of the cytotoxic cells generated in
vitro was further investigated by examining their proliferative
response to stimulation with different tumour antigens in vitro.
The data in Table 5.5 and 5.6 showed that the cytotoxic cells
raised against the MBL-2 tumour could also proliferate in
response to stimulation with other tumour antigens, though
maximum proliferation was always achieved in the presence of the
specific MBL-2 antigens. Moreover, the effect of exogenous IL-2
on the proliferative response of the cytotoxic cells was also
studied. It was found that 1. in the presence of 10% IL-2, there
was a drastic increase in the rate of cell proliferation; and 2.
the proliferative response was similar irrespective of the
I a b 1 e 5.5 P r o 1iferative response of the in vitro generated
cytotoxic cells to various tumours
l-TdR incorporation (CPM+ S.E.)
Stimulator cells
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C57 BL6J mice in groups of 4 were cyclophosphamide pretreated
(100 mgkg given i.p.) 2 days before i.v. injection with 10
MMC-inactivated MBL-2 cells. The mice were sacrificed 6 days
after tumour immunization and their spleen cells were co-cultured
with MMC-inactivated MBL-2 cells at a responder-to-stimulator
cell ratio of 20:1 in 75 cm2 tissue culture flasks for 5 days.
After the removal of dead cells and debris by centrifugation on
Ficol1-Isopaque gradient, the viable cells were further cultured
for 2 days in the absence of any stimulator cells. These
responder cells were then co-cultured with various MMC-treated
tumour stimulator cells at a responder:stimulator ratio of 5:1
( 5 x 104 responderswel1) in a 96-well flat-bottomed microtiter
plate in the absence or presence of IL-2. Two days later, each
well was then pulsed with 0.5 uCi 3H-TdR for 16 hrs and the
incorporated radioactivity was determined.
Table 5.6 Proliferative response of the in vitro generated
cytotoxic cells to various tumours





















C57BL6J mice in groups of 4 were cyclophosphamide pretreated
(100 mgkg give i.p.) on day -2 followed by i.v. injection with
107 MMC-inactivated MBL-2 cells on both day 0 and day 21. The
mice were sacrificed 3 days after the second tumour immunization
and their spleen cells were co-cultured with MMC-inactivated MBL-
2 cells at a responder-to-stimulator cell ratio of 20:1 in 75 cnf
tissue culture flasks for 5 days. After the removal of dead
cells and debris by centrifugation on Ficol1-1sopaque gradient,
the viable effector cells were further incubated for 2 days in
the absence of any stimulator cells. These responder cells were
then co-cultured with various MMC-treated tumour stimulator cells
at a responder:stimulator ratio of 5:1( 5 x 104 responderswe 11)
in a 96-well flat-bottomed microtiter plate in the absence of
presence of IL— 2. Two days later, each well was pulsed with 0.5
uCi 3H-TdR for 16 hrs and the incorporated radioactivity was
determined.
absence or presence of tumour antigens.
5.3 Determination of the phenotype of the cytotoxic cells
generated in vitro
As shown previously, cytotoxic cells can be obtained by in
vitro stimulation of the in vivo primed immune spleen cells.
The phenotype of these cytotoxic effector cells was determined by
treatment of the effector cells with monoclonal anti-Thy 1.2
antibody plus complement as described in Materials and Methods.
The untreated or complement-treated cells served as the positive
controls. These three groups of effector cells were incubated
with 51Cr-labe 1 led tumour targets including MBL-2, P815 and EL-4
cells and cytotoxicity was determined in a 8 hr Cr-release
assay. As shown in Table 5.7 and 5.8, complement treatment alone
did not affect the cytotoxic activity of the effector cells
whereas depletion of T cells by treatment with anti-Thy 1.2
antibody and complement greatly diminished the cytotoxic activity
of the effector cells against various tumour targets, indicating
that the cytotoxic activity was T-cell mediated.
Table 5.7 Elimination of the cytotoxic activity generated in
vitro by anti-Thy 1.2 antibody and complement treatment
Treatment of
ef f ector
cells with E: T@
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24 .1+ 0. 6
13.7±0. 6
2 2.1± 0. 6
0.2 ±1.3
0
C57BL6J mice in groups of 4 were cyclophosphamide pretreated
(100 mgkg given i.p.) 2 days before i.v. injection with 10 MMC-
inactivated MBL-2 cells. The mice were sacrificed 6 days after
tumour immunization and their spleen cells were co-cultured with
MMC-inactivated MBL-2 cells at a responder-to-stimulator cell
ratio of 20:1 in 75 cm2 tissue culture flasks for 5 days. After
the removal of dead cells and debris by centrifugation on Ficoll-
Isopaque gradient, the viable effector cells were depleted of T
cells by anti-Thy 1.2 antibody and complement treatment as
described in Materials and Methods. The treated cells were then
tested for cytotoxic activity against MBL-2, EL-4 and P815 target
cells in a 8 hr 51Cr release assay.
□ Effector-to-target cell ratio.
lable 5.8 Elimination of the cytotoxic activity generated in
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C57BL6J mice in groups of 4 were cyclophosphamide pretreated
(100 mgkg given i.p.) on day -2 followed by i.v. injection with
107 MMC-inactivated MBL-2 cells on both day 0 and day 21. The
mice were sacrificed 3 days after the second tumour immunization
and their spleen cells were co-cultured with MMC-inactivated MBL-
2 cells at a responder-to-stimulator cell ratio of 20:1 in 75 crrf
tissue culture flasks for 5 days. After the removal of dead
cells and debris by centrifugation on Ficol1-1sopague gradient,
the viable effector cells were depleted of T cells by anti-Thy
1.2 and complement treatment as described in Materials and
Methods. The treated cells were tested for cytotoxic activity
against MBL—2, EL —4 and P815 target cells in a 8 hr Cr release
assav.
□ Effector-to-target cell ratio,
DISCUSSION
Previous work in this laboratory have shown that cytotoxic
cells against the syngeneic MBL-2 tumour can be induced in vitro
by culturing normal C57BL6J mouse splenocytes for 5-6 days in
the presence of mitomycin C-inactivated MBL-2 cells (Wong, 1987).
In order to establish the optimal conditions for the induction of
MBL-2-reactive cytotoxic cells, the effect of specific in_ vivo
and in vitro immunizations on the generation of cytotoxic
activity against syngeneic MBL-2 tumour was examined. The
present data showed that both primary and secondary in vivo
immunized spleen cells did not exhibit any significant
cytotoxicity against MBL-2 cells. However, when these immune
spleen cells were co-cultured with MMC-inactivated MBL-2 cells
for 5 days, high levels of cytotoxic activity against the
syngeneic MBL-2 target were detected. In addition, the
cytotoxicity generated from primary and secondary in. vivo
immunized splenocytes were of similar magnitudes. The present
results are in line with others who found that the generation of
in vitro cytotoxicity against tumours required both culture with
specific tumours as well as previous in vivo priming (Bernstein
et al., 1976; Cheever et al., 1978; Nakano and Masuda, 1983a,b).
The failure to elicit a detectable cytotoxic response by in vivo
immunization with MBL-2 cells may be attributed to the inadequate
number of effector cells resulting from poor sensitization in
vivo. However, this is considered to be less likely because 1)
significant cytotoxic activity can be generated in vitro simply
by culturing the primary immune spleen cells in the absence or
presence of specific antigen; and 2) repeated in vivo
immunizations with a high dose of tumour still failed to induce a
detectable cytotoxic response. Alternatively, the inability to
generate a cytotoxic response to MBL-2 cells i_n vivo may be due
to factors in the host which limit or interfere with the
generation andor expression of cytotoxic effectors, such as
tumour-induced immunosuppression, formation of blocking
antibodies and suppressor cells etc. Such a possibility is
supported by the earlier finding that the MBL-2 tumour could
induce both suppressor cells and suppressor factors in vivo
(Wong, 1987). Thus it is conceivable that culturing of cells
primed in. vivo may by-pass suppressor mechanisms and resulted in
the generation of potent cytotoxic activity in vitro. Moreover,
it should be noted that a significant level of cytotoxicity
against the MBL-2 target could also be observed by culturing the
primary or secondary immune cells in the absence of exogenous
tumour antigens, indicating the the presence of specific tumour
in vitro may not be an absolute reguirement for the induction of
cytotoxic effector cells. However its presence may optimize the
response by inducing specific clonal expansion of effector cells
in vitro. In addition, it was found that pretreatment of mice
with cyclophosphamide before in vivo immunizations slightly
enhanced the cytotoxic response generated in vitro. How CY can
enhance the effect of in vivo priming is as yet unclear. It was
suggested that administration of CY prior to immunization might
result in nonspecific elimination of suppressor T cells and thus
stronger anti —tumour response could be developed (Glaser, 19 7 9 j
Hengst et al., 1981).
In order to determine the specificity of the cytotoxic
response generated in_ vitro, different tumour cells including
P815 and EL-4 cells were used as targets. It can be seen that
the cytotoxic cells derived from Ln vitro restimulation of in
viVQ primed cells could efficiently lyse these 'third-party'
tumour targets although these activated cells showed much higher
cytotoxicity against the MBL-2 cells that were used for i_n vivo
and iri vitro immunizations. A cross-reactivity in the in vitro
generated cytotoxic cells was also reported by other
investigators (Nakano and Masuda, 1983a,b). Moreover, the cross-
reactivity of the cytotoxic cells generated in vitro was also
detected in their proliferative response to stimulation with
different tumour antigens i_n vitro In the absence of exogenous
IL-2, the cytotoxic cells demonstrated maximum proliferative
response to stimulation with MBL-2 tumour antigens, yet they also
proliferated in response to other tumour antigens. However, in
the presence of 10% IL-2, the cytotoxic cells become greatly
dependent on IL-2 for proliferation and their specific response
to tumour antigens could no longer be demonstrated. These
results, when taken together, indicated that the cytotoxic
effector cells generated in vitro were guite heterogeneous in
nature and they exhibited some nonspecific cytotoxic activity
against other tumours. Moreover, the ability of these cytotoxic
cells to proliferate rapidly in response to IL-2 strongly
suggested that in vitro immunization might also induce the
expression of IL-2 receptors on these cultured cells.
As an initial attempt to characterize the nature of these
cytotoxic cells, they were depleted of T cells by treatment with
monoclonal anti-Thy 1.2 antibody and complement. It was found
that the cytotoxic activity against various tumour targets was
markedly diminished by depletion of T cells, indicating that the
cytotoxic activity generated in vitro was largely T-cell
mediated. The high reactivity of the cytotoxic cells towards
the MBL-2 tumour strongly suggested that the effector cell might
contain MBL-2-specific cytotoxic T lymphocytes. However, since
cross-reactivity was unambiguously demonstrated with other tumour
targets, it is conceivable that the effector cells might also
contain other types of nonspecific killer cells. It has been
known that cytotoxic cells which nonspecifically lyse a variety
of targets including the autologous tumour cells can also be
generated jLn vitro by culturing lymphocytes with autologous
tumours or in the presence of IL-2. These cells have been
referred to as 'anomalous killers',' natural-ki 1 ler-1 ike cells',
•activated lymphocyte killer (ALK) cells' and 'lymphokine
activated killer (LAK) cells (Herberman et al., 1987; Hersey and
Bolhuis, 1987). At present, how many types of cytotoxic cells
are activated by in vitro immunization with MBL-2 tumour have yet
to be resolved. The results so far suggested that NK or NK-like
cells are unlikely to be the major cell type responsible for the
in vitro cytotoxicity as two NK-insensitive tumour targets (i.e.
P815 and EL-4 cells) were killed efficiently by cytotoxic cells
generated in vitro. Moreover, the in vitro generated cells were
found to be highly sensitive to anti-Thy 1.2 plus complement
treatment whereas NK cells were reported to be much less
sensitive to such a treatment (Jondal, 1987). On the other hand,
the cytotoxic cells were generated iri vitro in the absence of any
exogenous IL-2, suggesting that the LAK cells might not be
involved in the observed cytotoxicity against tumours.
Nevertheless, it is still possible that the endogenous IL-2
produced by stimulation with MBL-2 antigens might activate the
cultured cells to become LAK cells. Furthermore, the cytotoxic
cells generated iri vitro might also contain the so called ALK
cells as this type of cytotoxic cells are MHC-unrestricted in
their lytic activity and they all carry the T cell marker (Hersey
and Bolhuis, 1987).
In order to dissect the heterogeneity of these cytotoxic T
cells, cloning methods have to be introduced so as to identify
the cytotoxic subset(s) of lymphocytes and to determine the
nature of tumour antigens recognized by the activated
lymphocytes. More recently, a few long-term IL-2 dependent T
cell lines have been established by repetitive in vitro
restimulation of the cytotoxic cells with MBL-2 antigens in the
presence of 10% IL-2. Although these cells lines have retained
antigen-specificity in their proliferative response to
stimulation with MBL-2 tumour antigens, yet their cytotoxic
activity seemed to decrease gradually upon long term culturing
(data not shown). It has been suggested that the lytic activity
of some cytotoxic T cells may be rapidly downregulated by long
term culture in the presence of IL-2 (Shih and Truitt, 1987).
Whether a similar feedback mechanism is operative in our system
remains to be established.
OF.NFRAT, nT SCn.F Q TOT
The most important tool employed in my research project for
measuring cytotoxicity against tumours is the 51Cr-release assay
which determines the percentage lysis of tumour cells. This
technique was first introduced by Brunner et al. (1968) for the
51
ce11-mediated lytic assays. The mechanism of the Cr release
assay can be illustrated as follows. 51Cr enters into the target
cells and binds to the negatively charged cytoplasmic proteins
51
tightly during the labelling of target cells with Cr.
51
Therefore, only when the cell membranes of Cr-labelled target
cells are damaged seriously will the 51Cr-label led proteins
(80kd-125kd) be released into the extracellular medium and their
associated radioactivity can then be determined. It has been
reported that the percentage of 5,Cr release is proportional to
the percentage of cell lysis (Berke, 1980; Schlager and Adams,
51
1983). The Cr releasse assay has the advantages of the ability
to handle large number of samples and to scale down the
cytotoxicity test so as to reduce the quantities of reagents used
as well as having greater precision. However, it exhibits early
and high spontaneous release with most tumour targets so it is
unsuitable for long incubation assays. Moreover, it cannot be
used at low target cell concentrations. There are other
techniques for monitoring the viability and disintegration of
cells (Vaage and Agarwal, 1978; Schlager and Adams, 1983). One
of these techniques is the trypan blue dye exclusion method. The
basis of this method is that only dead cells will take up the dye
whereas viable cells will exclude the dye. Therefore, dead cells
and viable cells can be distinguished clearly when viewed through
the microscope. Although this method is simple, rapid and
involves minimal manipulation of cells, however, it has an
inherent standard error due to the practical limit to the number
of cells that can be counted under the microscope. Moreover, it
is unreliable for quantitation of target cell death in a cell-
mediated cytotoxicity assay because the dead effector and target
cells will both be stained and they can hardly be distinguished
under the microscope. On the other hand, the 3H-thymidine
release method has often been used in most long-term cell-
mediated cytotoxicity assays. However, the time required for
3
labelling target cells with H-thymidine is quite long.
3
Moreover, the release of H-thymidine-label led DNA requires the
destruction of nuclear envelope. Therefore, it is insensitive
for short term assays. Based on the above considerations and
since most experiments in my thesis work require a sensitive
technique for the determination of percentage lysis of tumour
cells within 6-10 hrs, the 51Cr release assay was deliberately
chosen for my study.
In contrast to previous reports (Forman and Moller, 1973;
Bevan and Cohn, 1975; Bonavida and Bradley, 1976; Bradley and
Bonavida, 1978), it was found that normal mouse splenocytes could
be induced to lyse both syngeneic and allogeneic tumour cells in
vitro by lectins. The lectins tested include PHA, Con A and its
succinylated derivative (sCon A). How these lectins can trigger
nonspecific cytotoxicity in normal mouse lymphocytes is as yet
unclear. All these lectins are known to be mitogenic to T cells.
Moreover, they can also cross-link effector and target cells.
Our data so far indicate that the activation of normal
splenocytes alone by mitogenic lectins may not be sufficient to
induce cytolysis of tumours as it was found that pretreatment of
effector cells with sCon A for 1 hr failed to induce significant
lymphocyte-mediated cytotoxicity. However, whether cross-linking
of effector-to-target alone is sufficient for cytolysis to occur
has not yet been determined. For future investigations, non-
mitogenic plant lectins such as wheat germ agglutinin (WGA),
peanut agglutinin (PNA) and soyabean agglutinin (SBA) or agents
such as poly L-lysine, which readily agglutinate effector and
target cells, should be examined for their ability to induce
normal splenocytes to kill tumour targets i_n vitro.
Previous work had shown that increasing concentrations of
succinyl Con A, unlike that of Con A, did not inhibit membrane
mobility or lymphocyte proliferation (Hadden et a_l., 1976).
Similarly, the present investigation showed that Con A but not
sCon A exhibited diminished ability on induction of splenocyte
cytotoxicity against YAC-1 and MBL-2 targets at higher
concentrations. Why Con A and sCon A exhibited different dose-
response curves on induction of nonspecific lymphocyte-mediated
cytotoxicity is not entirely clear. However, it was reported
that Con A could raise intracellular cAMP level at high
concentrations whereas the same concentration of sCon A had no
appreciable effect on cAMP level (Hadden et al., 1976). It has
well been established that cAMP can suppress the lytic ability of
specific CTL as well as its proliferation. cAMP may also play£
role in regulating the lytic apparatus of lymphocytes.
Therefore, it would be of great interest to examine whether cAMI
can suppress the lectin-induced cytolysis of tumours. This car
be achieved by using drugs such as cholera toxin that can raise
intracellular cAMP level and its effect on the induction of LDCC
will then be evaluated. Moreover, whether cGMP may also play£
role in regulating lectin-induced cytolysis is worth
investigating.
Our data have shown that different tumour targets have
different susceptibility to lectin-induced cytolysis. These
results seem to indicate that lectin interaction with target cell
structure is required for LDCC to occur. However, it is known
that lectins can bind to the carbohydrate portion of several
distinct cell surface glycoproteins on either the effector or
target cells. Therefore, it is still uncertain whether the
lectins work 'exclusively' by modifying surface structures on
the effector cell, the target cell or on both cells. A recent
report has shown that Con A must act on a papain-sensitive, N-
glycosylated surface component to render target cell susceptible
to CTL-mediated lysis (Gorman et al., 1987). Whether there is a
similar target cell structure requirement in the lectin-induced
cytolysis in our system is unknown. Moreover, the importance of
MHC antigens and other surface molecules on the effector and
target cells in mediating LDCC has yet to be defined.
Although the present work clearly demonstrated that lectins
can induce normal splenocytes to lyse both syngeneic anc
allogeneic tumours. However, the in vivo effect of lectins on the
growth of tumours has not yet been investigated. Kataoka et al.
(1983) had shown that Con A-treated tumour cells could induce
stronger tumour-specific immunity than untreated tumour cells
when injected into syngeneic animals. Interestingly enough, it
has been reported that tumour cells preincubated with animal
lectins in. vitro had diminished ability to grow in vivo (Yamazaki
et a_l., 1983). In view of these findings, it would be of great
interest and importance to examine whether lectins can exert an
anti-tumour effect in vivo. Therefore in our future experiments
normal splenocytes pretreated with lectins in vitro will be
examined for their ability to prolong the life of tumour-bearing
animals upon adoptive transfer. In addition, tumour cells
pretreated with lectins in vitro will be tested for their
susceptibility to lymphocyte-mediated killing in vivo. Moreover,
the ability of lectin-treated tumours to induce a greater immune
response in the host will also be evaluated.
In the present study, it was found that PMA but not A23187
alone was able to trigger normal splenocytes to mediate
cytolysis against various tumour targets. In addition, PMA and
A23187 synergistically activated normal splenocytes to mediate
nonspecific cytotoxicity. This synergism has been suggested to
be related to the Ca++ and PMA activation requirements of protein
kinase C (PKC). Although there is evidence to suggest that most,
if not all, effects of phorbol esters are mediated through
activation of PKC (Nishizuka, 1984; 1986), nevertheless, it has
been reported that phorbol ester such as PMA has more effects
than just PKC activation, including modification of T cell
surface antigens (Bensussan et aJN, 1985) or acting as a membrane
fusigen or perturber (Nishizuka, 1984). Therefore, in order to
establish that PKC activation is essential in triggering normal
splenocytes to lyse tumour targets, two different experimental
approaches can be adopted. One approach is to measure the PKC
activity directly in cells that are activated with PMA andor
A23187. Alternatively, the effect of other pharmacologic agents
such as dihydroteleocidin B (a tumour promoter that can activate
PKC but is structurally unrelated to PMA) and 4-alpha-phorbol-
12,13-didecanote (a phorbol ester analogue which neither promotes
tumours nor activates PKC) on the induction of splenocyte
cytotoxicity against tumours should be examined.
The work in this thesis have shown that a short term
incubation of normal spleen cells with PMA andor A23187 can lead
to significant lysis of various tumour targets, however, the
effect of long term incubation with these drugs on the induction
of cytolysis has not yet examined. Interestingly, others had
demonstrated that short term incubation with murine and human CTL
with phorbol ester would result in significant triggering of CTL
whereas prolonged incubation had a negative effect on the CTL
lytic capacity (Russell, 1986; Schrezenmeier et al., 1986).
Whether a similar effect will be seen with the normal mouse
splenocytes has yet to be determined.
The present investigation showed that the cytotoxic activity
was mediated by T-cell in both lectin- and drug- induced
cytolysis. However, which T-cell subset plays a major role in
these types of cytotoxicity remains obscure. A recent report
showed that the LDCC activity exhibited by isolated 0KT8 T cells
was found to be supperior to that by 0KT4+ T cells and
unfractionated T lymphocytes (Perl et a_l., 1984). Therefore in
future experiments, fractionation of the normal spleen cells into
helper and suppressor populations or depletion of specific T cell
subsets by monoclonal antibody and complement treatment may
provide better insights into the nature of effector cells
mediating nonspecific cytotoxicity against tumours. Moreover,
other reports have shown that murine macrophages can be activated
by phorbol ester and calcium ionophore to kill tumour cells
(Somers et ad., 1986). Whether lectins may also induce
macrophages to kill tumour cells in vitro remains to be seen.
The generation of cytotoxic T cells against a syngeneic
tumour (MBL-2) by in vitro immunization of tumour-immune cells
has been established in our laboratory. It was found that
primary or secondary in vivo immunized cells rather than normal
cells could be stimulated in vitro to develop potent cytotoxic
activity against the syngeneic MBL-2 tumour. In addition,
pretreatment of mice with cyclophosphamide before immunization
could enhance the anti-tumour ability of effector cells generated
in vitro. These cytotoxic cells were found to be T-cells.
However, they also exhibited cross-reactivity with other tumours.
These results suggest that, these cytotoxic cells are likely to
be heterogeneous in nature and they may contain other cell types
such as LAK cells or ALK cells other than specific CTL. In order
to dissect the heterogeneity of these cytotoxic cells, cloning of
these effector cells is essential. Our preliminary work showed
that these cytotoxic cells could be maintained in vitro for more
than 3 months by repetitive in vitro restimulation with sonicated
MBL-2 tumour antigens in the presence of 10% IL-2. Although
these cells seemed to have retained the T cell marker and antigen
specificity, their lytic activity decreased gradually upon long
term culture. As it has been suggested that a downregulation in
the lytic activity in CTL may be induced by long term exposure to
IL-2 (Shin and Truitt, 1987), modifications in the culture
procedures may be necessary. Suggestions include the alternate
culturing of effector cells in the presence of either recombinant
IL-2 or tumour antigens and the use of intact tumour cells for
long term stimulation. Using such strategies it is hoped that
tumour-specific T cell clones can be established in our
laboratory in the forseeable future.
In conclusion, our results so far suggest that normal mouse
T lymphocytes can be triggered by different agents (specific
tumour antigens, lectins and pharmacologic agents) to exhibit
specific or nonspecific cytotoxic activity against tumours in
vitro. It would be of great interest to know whether the same
signal transduction pathways are set in motion by the multiple
activating agents. Moreover, whether there is any parallel
between LDCC and drug-induced killing and whether PMA andor
A23187 can synergize with plant lectins in inducing splenocyte
cytotoxicity are intriguing aspects that remain to be explored.
Finally, whether these cytotoxic cells generated _in vitro can
demonstrate similar anti-tumour activity iri vivo awaits further
investigation.
ABSTRACI
Mitogenic plant lectins such as PHA, Con A and succinyl
Con A (sCon A) were found to induce significant splenocyte
cytotoxicity against a variety of syngeneic and allogeneic tumour
targets. The data showed that both Con A and sCon A were much
potent than PHA for the induction of lectin-dependent cellular
cytotoxicity (LDCC). sCon A differed from Con A in that its
ability to induce LDCC was not diminished at higher lectin
concentrations. Moreover, different tumour targets showed
different susceptibility to lectin-induced cytolysis. Cytolysis
was found to be T ce11-mediated and dependent on the presence of
Ca++ and appropriate temperature (37 °C). The guestion remains
open as to what the lectin is providing in the cytotoxic assay.
The results clearly showed that pretreatment of effector andor
target cells with Con A but not sCon A could induce significant
LDCC against the MBL-2 and YAC-1 tumours. In addition, cytolysis
was abolished by the addition of a-methy1-D-mannoside to the
assay system indicating that the binding of lectins to the
effector andor target cell surface may be critical for lysis to
occur. Furthermore, several pharmacologic agents such as H7 (an
inhibitor of protein kinase c) and W7 (a calmodulin antagonist)
were found to be inhibitory to LDCC suggesting that the lectin-
induced cytolysis may also depend on signal transduction pathways
to effect target cell lysis.
It has been known that phorbol ester, a potent activator of
protein kinase C, when present alone or in combination with
calcium ionophore, can mimic antigenic stimulation and is
effective in triggering T cell activation. The present work
showed that PMA (a phorbol ester) but not A23187 (a calcium
ionophore) alone was able to trigger normal mouse splenocytes to
display a significant, albeit low, level of cytotoxicity against
tumours. This nonspecific cytotoxicity was dependent on the
concentration of PMA and could be observed with various tumour
targets. In addition, the PMA- induced cytotoxicity was found to
be significantly enhanced with the stimultaneous presence of
A23187. Time course experiments showed that the PMA andor
A23187-induced splenocyte cytotoxicity occurred rapidly and
significant cytolysis of tumour targets was detected at 4 hrs
after incubation of effector and target cells. The rapid
kinetics indicate that the cytolysis induced by PMA andor A23187
may result primarily from the triggering of conventional lytic
mechanisms rather than through activation of lymphokine
production. A brief exposure of the effector cells to PMA andor
A23187 was found to be sufficient to induce cytolysis and the
effector cells mediating cytotoxicity were characterized to be T
lymphocytes.
The effect of in vivo and in vitro immunizations on the
generation of specific cytotoxic cells to a syngeneic tumour
(MBL-2) was investigated. It was found that potent cytotoxic T
cell activity directed against the MBL-2 tumour could be induced
by stimulation of the in vivo primed spleen cells for 5 days in
the presence of mitomycin C—treated MBL—2 tumour in vitro. The
data showed that the cytotoxic activity generated from the
primary or secondary in vivo immunized splenocytes were of
similar magnitudes. In addition, pretreatment of mice with
cyclophosphamide before in. vivo immunization slightly enhanced
the cytotoxic response generated in. vitro. Moreover, a cross-
reactivity in the cytotoxic cells generated in. vitro was
demonstrated by their ability to lyse other tumour targets as
well as their capacity to proliferate in response to stimulation
with other tumour antigens in vitro. Collectively, these results
indicate that the cytotoxic cells generated in vitro may be quite
heterogeneous in nature. Therefore, cloning of these cells is
required before they can be studied for their anti-tumour
activity in vivo.
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